,Change_Type,Covered_Recipient_Type,Noncovered_Recipient_Entity_Name,Teaching_Hospital_CCN,Teaching_Hospital_ID,Teaching_Hospital_Name,Covered_Recipient_Profile_ID,Covered_Recipient_NPI,Covered_Recipient_First_Name,Covered_Recipient_Middle_Name,Covered_Recipient_Last_Name,Covered_Recipient_Name_Suffix,Recipient_Primary_Business_Street_Address_Line1,Recipient_Primary_Business_Street_Address_Line2,Recipient_City,Recipient_State,Recipient_Zip_Code,Recipient_Country,Recipient_Province,Recipient_Postal_Code,Covered_Recipient_Primary_Type_1,Covered_Recipient_Primary_Type_2,Covered_Recipient_Primary_Type_3,Covered_Recipient_Primary_Type_4,Covered_Recipient_Primary_Type_5,Covered_Recipient_Primary_Type_6,Covered_Recipient_Specialty_1,Covered_Recipient_Specialty_2,Covered_Recipient_Specialty_3,Covered_Recipient_Specialty_4,Covered_Recipient_Specialty_5,Covered_Recipient_Specialty_6,Covered_Recipient_License_State_code1,Covered_Recipient_License_State_code2,Covered_Recipient_License_State_code3,Covered_Recipient_License_State_code4,Covered_Recipient_License_State_code5,Principal_Investigator_1_Covered_Recipient_Type,Principal_Investigator_1_Profile_ID,Principal_Investigator_1_NPI,Principal_Investigator_1_First_Name,Principal_Investigator_1_Middle_Name,Principal_Investigator_1_Last_Name,Principal_Investigator_1_Name_Suffix,Principal_Investigator_1_Business_Street_Address_Line1,Principal_Investigator_1_Business_Street_Address_Line2,Principal_Investigator_1_City,Principal_Investigator_1_State,Principal_Investigator_1_Zip_Code,Principal_Investigator_1_Country,Principal_Investigator_1_Province,Principal_Investigator_1_Postal_Code,Principal_Investigator_1_Primary_Type_1,Principal_Investigator_1_Primary_Type_2,Principal_Investigator_1_Primary_Type_3,Principal_Investigator_1_Primary_Type_4,Principal_Investigator_1_Primary_Type_5,Principal_Investigator_1_Primary_Type_6,Principal_Investigator_1_Specialty_1,Principal_Investigator_1_Specialty_2,Principal_Investigator_1_Specialty_3,Principal_Investigator_1_Specialty_4,Principal_Investigator_1_Specialty_5,Principal_Investigator_1_Specialty_6,Principal_Investigator_1_License_State_code1,Principal_Investigator_1_License_State_code2,Principal_Investigator_1_License_State_code3,Principal_Investigator_1_License_State_code4,Principal_Investigator_1_License_State_code5,Principal_Investigator_2_Covered_Recipient_Type,Principal_Investigator_2_Profile_ID,Principal_Investigator_2_NPI,Principal_Investigator_2_First_Name,Principal_Investigator_2_Middle_Name,Principal_Investigator_2_Last_Name,Principal_Investigator_2_Name_Suffix,Principal_Investigator_2_Business_Street_Address_Line1,Principal_Investigator_2_Business_Street_Address_Line2,Principal_Investigator_2_City,Principal_Investigator_2_State,Principal_Investigator_2_Zip_Code,Principal_Investigator_2_Country,Principal_Investigator_2_Province,Principal_Investigator_2_Postal_Code,Principal_Investigator_2_Primary_Type_1,Principal_Investigator_2_Primary_Type_2,Principal_Investigator_2_Primary_Type_3,Principal_Investigator_2_Primary_Type_4,Principal_Investigator_2_Primary_Type_5,Principal_Investigator_2_Primary_Type_6,Principal_Investigator_2_Specialty_1,Principal_Investigator_2_Specialty_2,Principal_Investigator_2_Specialty_3,Principal_Investigator_2_Specialty_4,Principal_Investigator_2_Specialty_5,Principal_Investigator_2_Specialty_6,Principal_Investigator_2_License_State_code1,Principal_Investigator_2_License_State_code2,Principal_Investigator_2_License_State_code3,Principal_Investigator_2_License_State_code4,Principal_Investigator_2_License_State_code5,Principal_Investigator_3_Covered_Recipient_Type,Principal_Investigator_3_Profile_ID,Principal_Investigator_3_NPI,Principal_Investigator_3_First_Name,Principal_Investigator_3_Middle_Name,Principal_Investigator_3_Last_Name,Principal_Investigator_3_Name_Suffix,Principal_Investigator_3_Business_Street_Address_Line1,Principal_Investigator_3_Business_Street_Address_Line2,Principal_Investigator_3_City,Principal_Investigator_3_State,Principal_Investigator_3_Zip_Code,Principal_Investigator_3_Country,Principal_Investigator_3_Province,Principal_Investigator_3_Postal_Code,Principal_Investigator_3_Primary_Type_1,Principal_Investigator_3_Primary_Type_2,Principal_Investigator_3_Primary_Type_3,Principal_Investigator_3_Primary_Type_4,Principal_Investigator_3_Primary_Type_5,Principal_Investigator_3_Primary_Type_6,Principal_Investigator_3_Specialty_1,Principal_Investigator_3_Specialty_2,Principal_Investigator_3_Specialty_3,Principal_Investigator_3_Specialty_4,Principal_Investigator_3_Specialty_5,Principal_Investigator_3_Specialty_6,Principal_Investigator_3_License_State_code1,Principal_Investigator_3_License_State_code2,Principal_Investigator_3_License_State_code3,Principal_Investigator_3_License_State_code4,Principal_Investigator_3_License_State_code5,Principal_Investigator_4_Covered_Recipient_Type,Principal_Investigator_4_Profile_ID,Principal_Investigator_4_NPI,Principal_Investigator_4_First_Name,Principal_Investigator_4_Middle_Name,Principal_Investigator_4_Last_Name,Principal_Investigator_4_Name_Suffix,Principal_Investigator_4_Business_Street_Address_Line1,Principal_Investigator_4_Business_Street_Address_Line2,Principal_Investigator_4_City,Principal_Investigator_4_State,Principal_Investigator_4_Zip_Code,Principal_Investigator_4_Country,Principal_Investigator_4_Province,Principal_Investigator_4_Postal_Code,Principal_Investigator_4_Primary_Type_1,Principal_Investigator_4_Primary_Type_2,Principal_Investigator_4_Primary_Type_3,Principal_Investigator_4_Primary_Type_4,Principal_Investigator_4_Primary_Type_5,Principal_Investigator_4_Primary_Type_6,Principal_Investigator_4_Specialty_1,Principal_Investigator_4_Specialty_2,Principal_Investigator_4_Specialty_3,Principal_Investigator_4_Specialty_4,Principal_Investigator_4_Specialty_5,Principal_Investigator_4_Specialty_6,Principal_Investigator_4_License_State_code1,Principal_Investigator_4_License_State_code2,Principal_Investigator_4_License_State_code3,Principal_Investigator_4_License_State_code4,Principal_Investigator_4_License_State_code5,Principal_Investigator_5_Covered_Recipient_Type,Principal_Investigator_5_Profile_ID,Principal_Investigator_5_NPI,Principal_Investigator_5_First_Name,Principal_Investigator_5_Middle_Name,Principal_Investigator_5_Last_Name,Principal_Investigator_5_Name_Suffix,Principal_Investigator_5_Business_Street_Address_Line1,Principal_Investigator_5_Business_Street_Address_Line2,Principal_Investigator_5_City,Principal_Investigator_5_State,Principal_Investigator_5_Zip_Code,Principal_Investigator_5_Country,Principal_Investigator_5_Province,Principal_Investigator_5_Postal_Code,Principal_Investigator_5_Primary_Type_1,Principal_Investigator_5_Primary_Type_2,Principal_Investigator_5_Primary_Type_3,Principal_Investigator_5_Primary_Type_4,Principal_Investigator_5_Primary_Type_5,Principal_Investigator_5_Primary_Type_6,Principal_Investigator_5_Specialty_1,Principal_Investigator_5_Specialty_2,Principal_Investigator_5_Specialty_3,Principal_Investigator_5_Specialty_4,Principal_Investigator_5_Specialty_5,Principal_Investigator_5_Specialty_6,Principal_Investigator_5_License_State_code1,Principal_Investigator_5_License_State_code2,Principal_Investigator_5_License_State_code3,Principal_Investigator_5_License_State_code4,Principal_Investigator_5_License_State_code5,Submitting_Applicable_Manufacturer_or_Applicable_GPO_Name,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Country,Related_Product_Indicator,Covered_or_Noncovered_Indicator_1,Indicate_Drug_or_Biological_or_Device_or_Medical_Supply_1,Product_Category_or_Therapeutic_Area_1,Name_of_Drug_or_Biological_or_Device_or_Medical_Supply_1,Associated_Drug_or_Biological_NDC_1,Associated_Device_or_Medical_Supply_PDI_1,Covered_or_Noncovered_Indicator_2,Indicate_Drug_or_Biological_or_Device_or_Medical_Supply_2,Product_Category_or_Therapeutic_Area_2,Name_of_Drug_or_Biological_or_Device_or_Medical_Supply_2,Associated_Drug_or_Biological_NDC_2,Associated_Device_or_Medical_Supply_PDI_2,Covered_or_Noncovered_Indicator_3,Indicate_Drug_or_Biological_or_Device_or_Medical_Supply_3,Product_Category_or_Therapeutic_Area_3,Name_of_Drug_or_Biological_or_Device_or_Medical_Supply_3,Associated_Drug_or_Biological_NDC_3,Associated_Device_or_Medical_Supply_PDI_3,Covered_or_Noncovered_Indicator_4,Indicate_Drug_or_Biological_or_Device_or_Medical_Supply_4,Product_Category_or_Therapeutic_Area_4,Name_of_Drug_or_Biological_or_Device_or_Medical_Supply_4,Associated_Drug_or_Biological_NDC_4,Associated_Device_or_Medical_Supply_PDI_4,Covered_or_Noncovered_Indicator_5,Indicate_Drug_or_Biological_or_Device_or_Medical_Supply_5,Product_Category_or_Therapeutic_Area_5,Name_of_Drug_or_Biological_or_Device_or_Medical_Supply_5,Associated_Drug_or_Biological_NDC_5,Associated_Device_or_Medical_Supply_PDI_5,Total_Amount_of_Payment_USDollars,Date_of_Payment,Form_of_Payment_or_Transfer_of_Value,Expenditure_Category1,Expenditure_Category2,Expenditure_Category3,Expenditure_Category4,Expenditure_Category5,Expenditure_Category6,Preclinical_Research_Indicator,Delay_in_Publication_Indicator,Name_of_Study,Dispute_Status_for_Publication,Record_ID,Program_Year,Payment_Publication_Date,ClinicalTrials_Gov_Identifier,Research_Information_Link,Context_of_Research
8515,UNCHANGED,Covered Recipient Teaching Hospital,,180036.0,9507.0,OUR LADY OF BELLEFONTE,,,,,,,1000 St Christopher Dr,,Ashland,KY,41101,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,960015.0,1952370066.0,KIRTI,,JAIN,,122 SAINT CHRISTOPHER DR,122 SAINT CHRISTOPHER DR,ASHLAND,KY,41101,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,,,,,,KY,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Merck Sharp & Dohme Corporation,100000000053,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Biological,ONCOLOGY,KEYTRUDA,0006-3029-02,,,,,,,,,,,,,,,,,,,,,,,,,,97.05,05/28/2020,In-kind items and services,,,,,,,No,No,"A Phase III, Randomized, Double-blind Trial of Platinum Doublet Chemotherapy ,- Pembrolizumab MK-3475 as Neoadjuvant,Adjuvant Therapy for Participants with Resectable Stage II, IIIA, and Resectable IIIB T3-4N2 Non-small Cell Lung Cancer NSCLC KEYNOTE-671",No,740717585,2020,01/20/2023,,,Equipment or non-drug supplies provided to a clinical study site.
1321,UNCHANGED,Covered Recipient Teaching Hospital,,230046.0,9198.0,UNIV OF MI HOSPITALS & HLTH CTRS,,,,,,,1500 East Medical Center Drive,,Ann Arbor,MI,48109,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,367708.0,1154443497.0,CAGRI,GIRAY,BESIRLI,,1000 WALL ST,,ANN ARBOR,MI,48105-1912,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Ophthalmology,,,,,,MI,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Regeneron Pharmaceuticals, Inc.",100000000069,"Regeneron Pharmaceuticals, Inc.",NY,United States,Yes,Covered,Biological,OPHTHALMOLOGY,EYLEA,61755-005-02,,,,,,,,,,,,,,,,,,,,,,,,,,225.0,03/19/2020,Cash or cash equivalent,,,,,,,No,No,"RANDOMIZED, CONTROLLED, MULTI-CENTER STUDY TO ASSESS THE EFFICACY, SAFETY, AND TOLERABILITY OF INTRAVITREAL AFLIBERCEPT COMPARED TO LASER PHOTOCOAGULATION IN PATIENTS WITH RETINOPATHY OF PREMATURITY",No,724448619,2020,01/20/2023,NCT04101721,,
1642,UNCHANGED,Covered Recipient Teaching Hospital,,230046.0,9198.0,Univ Of Mi Hospitals & Hlth Ctrs,,,,,,,1500 East Medical Center Drive,,Ann Arbor,MI,48109,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,11050.0,1235211764.0,RODICA,P,BUSUI,,1500 E MEDICAL CENTER DR,# 354,ANN ARBOR,MI,48109,United States,,,Medical Doctor,,,,,,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",,,,,,MI,OH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Novo Nordisk Inc,100000000163,Novo Nordisk AS,,Denmark,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2072.65,09/24/2020,Cash or cash equivalent,,,,,,,No,No,EX9536-4388,No,742381665,2020,01/20/2023,,,
694,UNCHANGED,Covered Recipient Teaching Hospital,,110010.0,9427.0,Emory University Hospital,,,,,,,1364 CLIFTON RD NE,,ATLANTA,GA,30322,United States,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Bristol Myers Squibb Company,100000005499,"E.R. Squibb & Sons, L.L.C.",NJ,United States,Yes,Covered,Biological,Oncology,OPDIVO,0003-3774-12,,,,,,,,,,,,,,,,,,,,,,,,,,572.41,01/06/2020,Cash or cash equivalent,,,,,,,No,No,Phase I II PK Multi Tumor SubQ Formulation Nivo Mono,No,736757913,2020,01/20/2023,,,
6179,UNCHANGED,Covered Recipient Teaching Hospital,,380009.0,9844.0,Ohsu Hospital And Clinics,,,,,,,3181 Sam Jackson Park Road,,Portland,OR,97239,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,83358.0,1821204934.0,EMMA,C,SCOTT,,3181 SW SAM JACKSON PARK RD,,PORTLAND,OR,97239-3011,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology,,,,,,OR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Janssen Research & Development, LLC",100000005592,"Janssen Research & Development, LLC",NJ,United States,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,788.0,12/03/2020,Cash or cash equivalent,,,,,,,No,No,"Randomized Phase 3 Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic AL Amyloidosis",No,719478499,2020,01/20/2023,,,
1252,UNCHANGED,Covered Recipient Teaching Hospital,,440015.0,9001.0,University Of Tennessee Medical Cent,,,,,,,1924 Alcoa Hwy,,Knoxville,TN,37920,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,172406.0,1801908223.0,TIMOTHY,J,PANELLA,,1926 ALCOA HWY STE 410,1926 ALCOA HWY STE 410,KNOXVILLE,TN,37920-1545,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,,,,,,TN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Merck Sharp & Dohme Corporation,100000000053,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Biological,ONCOLOGY,KEYTRUDA,0006-3029-02,,,,,,,,,,,,,,,,,,,,,,,,,,4489.86,03/14/2020,In-kind items and services,,,,,,,No,No,"Adjuvant Therapy with Pembrolizumab versus Placebo in Resected High Risk Stage II Melanoma A Randomized, Double-blind Phase III Study KEYNOTE 716",No,740738653,2020,01/20/2023,,,Equipment or non-drug supplies provided to a clinical study site.
488,UNCHANGED,Covered Recipient Teaching Hospital,,50146.0,9927.0,CITY OF HOPE NATIONAL MEDICAL CTR,,,,,,,1500 E Duarte Rd,,Duarte,CA,91010,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,1288877.0,1275761553.0,ALEX,F,HERRERA,,1500 DUARTE RD,1500 DUARTE RD,DUARTE,CA,91010-3012,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology,,,,,,CA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Merck Sharp & Dohme Corporation,100000000053,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Biological,ONCOLOGY,KEYTRUDA,0006-3029-02,,,,,,,,,,,,,,,,,,,,,,,,,,88829.28,11/15/2020,In-kind items and services,,,,,,,No,No,"A Phase I Study of Pembrolizumab Plus Vorinostat for Relapsed or Refractory Diffuse Large B-cell Lymphoma, Follicular Lymphoma, and Hodgkin Lymphoma",No,740702395,2020,01/20/2023,,,Study drug provided for an investigator-initiated clinical study.
5567,UNCHANGED,Covered Recipient Teaching Hospital,,230236.0,9149.0,Metropolitan Hospital,,,,,,,5900 BYRON CENTER AVE SW,,WYOMING,MI,49519,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,192983.0,1255312302.0,MATTHEW,W.,SEVENSMA,,5900 BYRON CENTER AVE SW,,WYOMING,MI,49519,United States,,,Doctor of Osteopathy,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease,,,,,,MI,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BIOTRONIK INC.,100000010579,BIOTRONIK INC.,OR,United States,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,16.25,01/08/2020,Cash or cash equivalent,,,,,,,No,No,BIO-LIBRA,No,751906891,2020,01/20/2023,,,
2029,UNCHANGED,Covered Recipient Teaching Hospital,,140158.0,9091.0,Mercy Hospital & Medical Center,,,,,,,2525 S Michigan Ave,,Chicago,IL,60616,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,359742.0,1922317528.0,MAJA,,DELIBASIC,,3753 S COTTAGE GROVE AVE,,CHICAGO,IL,60653,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine,,,,,,IL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Novo Nordisk Inc,100000000163,Novo Nordisk AS,,Denmark,Yes,Covered,Drug,Diabetes,Ozempic,0169-4132-12,,,,,,,,,,,,,,,,,,,,,,,,,,82.12,06/30/2020,In-kind items and services,,,,,,,No,No,NN9535-4352,No,742392463,2020,01/20/2023,,,
6861,UNCHANGED,Covered Recipient Teaching Hospital,,363300.0,8988.0,CHILDRENS HOSPITAL MEDICAL CENTER,,,,,,,3333 Burnet Ave,,Cincinnati,OH,45229,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,856784.0,1356304158.0,LARA,ANN,DANZIGER-ISAKOV,,3333 BURNET AVE,3333 BURNET AVE,CINCINNATI,OH,45229-3026,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Infectious Diseases,,,,,,OH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Merck Sharp & Dohme Corporation,100000000053,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Biological,INFECTIOUS DISEASE,ZINPLAVA,0006-3025-00,,,,,,,,,,,,,,,,,,,,,,,,,,111.6,12/16/2020,In-kind items and services,,,,,,,No,No,"Protocol Title  A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of a Single Infusion of Bezlotoxumab MK-6072, Human Monoclonal Antibody to C. difficile Toxin B in Children Aged 1 to 18 Years Receiving Antibacterial Drug Treatment for C. difficile Infection MODIFY III",No,740743797,2020,01/20/2023,,,Equipment or non-drug supplies provided to a clinical study site.
574,UNCHANGED,Covered Recipient Teaching Hospital,,330125.0,8790.0,ROCHESTER GENERAL HOSPITAL,,,,,,,1425 Portland Ave,,Rochester,NY,14621,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,80892.0,1770815540.0,SCOTT,C,FEITELL,,1415 PORTLAND AVE,,ROCHESTER,NY,14621,United States,,,Doctor of Osteopathy,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Advanced Heart Failure and Transplant Cardiology,,,,,,NY,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Abbott Laboratories,100000010680,Abbott Laboratories,IL,United States,Yes,Covered,Device,Cardiac Arrhythmias and Heart Failure,CardioMEMS HF System,,,,,,,,,,,,,,,,,,,,,,,,,,,4214.5,02/19/2020,Cash or cash equivalent,,,,,,,No,No,Hemodynamic-GUIDEd Management of Heart Failure,No,751755841,2020,01/20/2023,NCT03387813,,GUIDE-HF
6901,UNCHANGED,Covered Recipient Teaching Hospital,,450076.0,9670.0,UT MD ANDERSON CANCER CENTER,,,,,,,1515 HOLCOMBE BLVD,,HOUSTON,TX,77030,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,651986.0,1134380652.0,MATTHEW,T,CAMPBELL,,1400 HOLCOMBE BLVD,,HOUSTON,TX,77030,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine,,,,,,TX,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Pfizer Inc.,100000000286,PFIZER INC.,NY,United States,Yes,Covered,Drug,ONCOLOGY,BAVENCIO,44087-3535-1,,Covered,Drug,ONCOLOGY,INLYTA,0069-0145-01,,,,,,,,,,,,,,,,,,,,26394.0,11/30/2020,In-kind items and services,,,,,,,No,No,A PHASE 3 MULTINATIONAL RANDOMIZED OPENLABEL PARALLELARM STUDY OF AVELUMAB MSB0010718C IN COMBINATION WITH AXITINIB INLYTAREGISTERED VERSUS SUNITINIB SUTENTREGISTERED MONOTHERAPY IN THE FIRSTLINE TREATMENT OF PATIENTS WITH ADVANCED RENAL CELL CARCINOMA,No,742870251,2020,01/20/2023,,,Study Drug
2290,UNCHANGED,Covered Recipient Physician,,,,,46684.0,1043300726.0,SUE,,ECKHARDT,,1601 TRINITY ST STOP Z0200,,AUSTIN,TX,78712,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,,,,,,TX,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Genentech, Inc.",100000005656,F. Hoffmann-La Roche AG,,Switzerland,Yes,Covered,Biological,BioOncology,Tecentriq,50242-917-01,,,,,,,,,,,,,,,,,,,,,,,,,,2920.81,09/30/2020,In-kind items and services,,,,,,,No,No,A PHASE Ib STUDY OF THE SAFETY AND PHARMACOLOGY OF ATEZOLIZUMAB ANTI-PD-L1 ANTIBODY ADMINISTERED WITH BEVACIZUMAB ANDOR CHEMOTHERAPY IN PATIENTS WITH ADVANCED SOLID TUMORS,No,742990739,2020,01/20/2023,,,
9027,UNCHANGED,Covered Recipient Teaching Hospital,,380009.0,9844.0,OHSU HOSPITAL AND CLINICS,,,,,,,3181 Sw Sam Jackson Park Rd,,Portland,OR,97239,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,183323.0,1033127584.0,CHRISTOPHER,W,RYAN,,3303 SW BOND AVE,3303 SW BOND AVE,PORTLAND,OR,97239-4501,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,,,,,,OR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Merck Sharp & Dohme Corporation,100000000053,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Biological,ONCOLOGY,KEYTRUDA,0006-3029-02,,,,,,,,,,,,,,,,,,,,,,,,,,9618.08,02/25/2020,Cash or cash equivalent,,,,,,,No,No,"A Phase III Randomized, Open-label Study to Evaluate Efficacy and Safety of Pembrolizumab MK-3475 in Combination with Axitinib versus Sunitinib Monotherapy as a First-line Treatment for Locally Advanced or Metastatic Renal Cell Carcinoma mRCC KEYNOTE-426",No,740811993,2020,01/20/2023,,,
1127,UNCHANGED,Covered Recipient Teaching Hospital,,100271.0,9478.0,H. Lee Moffitt Cancer Center,,,,,,,12902 MAGNOLIA DR,,TAMPA,FL,33612,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,873368.0,1922365477.0,ROHIT,KUMAR,JAIN,,12902 USF MAGNOLIA DR,,TAMPA,FL,33612-9416,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,,,,,,FL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Bavarian Nordic A/S,100000796825,Bavarian Nordic A/S,,Denmark,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,269.0,09/15/2020,Cash or cash equivalent,,,,,,,No,No,CV301-BLD-001: CV301 Combined With PD-1/L1 Blockade in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer,No,735529813,2020,01/20/2023,,,
7645,UNCHANGED,Covered Recipient Physician,,,,,136863.0,1023104445.0,MAYANK,,GUPTA,,8550 MARSHALL DR STE 150,,OVERLAND PARK,KS,66214,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Anesthesiology|Pain Medicine,,,,,,KS,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BIOTRONIK INC.,100000010579,BIOTRONIK INC.,OR,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,150.0,03/10/2020,Cash or cash equivalent,,,,,,,No,No,BENEFIT-02,No,751883371,2020,01/20/2023,,,
4986,UNCHANGED,Covered Recipient Teaching Hospital,,520138.0,9200.0,Aurora Health Care Metro Inc.,,,,,,,2900 W OKLAHOMA AVE,,MILWAUKEE,WI,53215,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,761010.0,1962479527.0,ATUL,,BHATIA,,2801 W Kinnickinnic River Pkwy,Ste 777,Milwaukee,WI,53215,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology,,,,,,WI,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Medtronic Vascular, Inc.",100000010384,"Medtronic Vascular, Inc.",MN,United States,Yes,Covered,Device,Implantable Cardioverter Defibrillators (ICDs),Viva,,,,,,,,,,,,,,,,,,,,,,,,,,,2518.0,02/12/2020,Cash or cash equivalent,,,,,,,No,No,AdaptResponse,No,728048777,2020,01/20/2023,,,
7256,UNCHANGED,Covered Recipient Teaching Hospital,,500027.0,9811.0,SWEDISH MEDICAL CENTER,,,,,,,747 Broadway,,Seattle,WA,98122,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,289631.0,1376633222.0,JOHN,,PAGEL,,1221 MADISON ST,,SEATTLE,WA,98104,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,,,,,,WA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Kite Pharma, Inc.",100000216809,"Kite Pharma, Inc.",CA,United States,Yes,Covered,Drug,CELLT,Yescarta,71287-119-02,,,,,,,,,,,,,,,,,,,,,,,,,,36563.08,02/13/2020,Cash or cash equivalent,,,,,,,No,No,"A Phase 3, Randomized, Open-Label Study Evaluating the Efficacy of Axicabtagene Ciloleucel versus Standard of Care Therapy in Subjects with Relapsed/Refractory Diffuse Large B Cell Lymphoma (ZUMA 7)",No,732772877,2020,01/20/2023,,,;KTE-C19-107;KP20543;KPCROS;910433740;11262692
4543,UNCHANGED,Covered Recipient Teaching Hospital,,60022.0,9291.0,MEMORIAL HEALTH SYSTEM,,,,,,,1400 EAST BOULDER STREET,,COLORADO SPRINGS,CO,80909,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,328086.0,1245219435.0,ROBERT,J,HOYER,,525 N FOOTE AVE STE 202,,COLORADO SPRINGS,CO,80909,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,,,,,,CO,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Eli Lilly and Company,100000000088,Eli Lilly and Company,IN,United States,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,24723.7,01/22/2020,Cash or cash equivalent,,,,,,,No,No,A RANDOMIZED PHASE 2 TRIAL OF AM0010 IN COMBINATION WITH PEMBROLIZUMAB VS. PEMBROLIZUMAB ALONE AS FIRST-LINE THERAPY IN PATIENTS WITH METASTATIC NON-SMALL CELL LUNG CANCER WHOSE TUMORS HAVE HIGH PD-L1 EXPRESSION,No,728728747,2020,01/20/2023,,,"The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor"
400,UNCHANGED,Covered Recipient Teaching Hospital,,230297.0,8803.0,KARMANOS CANCER HOSPITAL,,,,,,,4100 John R St,,Detroit,MI,48201,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,928426.0,1841453404.0,ERLENE,K,SEYMOUR,,4201 SAINT ANTOINE ST,STE 7B,DETROIT,MI,48201-2153,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine,,,,,,MI,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Takeda Pharmaceuticals U.S.A., Inc.",100000000337,"Takeda Pharmaceuticals U.S.A., Inc.",IL,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1480.2,11/24/2020,Cash or cash equivalent,,,,,,,No,No,"A STUDY TO EVALUATE THE SAFETY, TOLERABILITY AND PHARMACOKINETICS (PK) OF TAK-981 IN ADULT PARTICIPANTS WITH ADVANCED OR METASTATIC SOLID TUMORS OR RELAPSED/REFRACTORY HEMATOLOGIC MALIGNANCIES AND IN A SUBSET WITH CORONAVIRUS DISEASE 2019 (COVID-19)",No,737062643,2020,01/20/2023,,,
6488,UNCHANGED,Covered Recipient Teaching Hospital,,110010.0,9427.0,EMORY UNIVERSITY HOSPITAL,,,,,,,1364 Clifton Rd Ne,,Atlanta,GA,30322,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,438543.0,1639480106.0,MEHMET,,AKCE,,5333 MCAULEY DR,5333 MCAULEY DR,YPSILANTI,MI,48197-1014,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,,,,,,GA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Merck Sharp & Dohme Corporation,100000000053,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Drug,ONCOLOGY,LENVIMA,62856-712-30,,,,,,,,,,,,,,,,,,,,,,,,,,1505.96,11/02/2020,In-kind items and services,,,,,,,No,No,"A Phase 3 Multicenter, Randomized, Double-blinded, Active-controlled, Clinical Study to Evaluate the Safety and Efficacy of Lenvatinib E7080,MK-7902 in Combination with Pembrolizumab MK-3475 Versus Lenvatinib in First-line Therapy of Participants with Advanced Hepatocellular Carcinoma LEAP-002",No,740753781,2020,01/20/2023,,,Study drug provided to a clinical study site.
9264,UNCHANGED,Covered Recipient Physician,,,,,676392.0,1992723654.0,JAME,,ABRAHAM,,10201 CARNEGIE AVE,,CLEVELAND,OH,44106,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,,,,,,OH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Eli Lilly and Company,100000000088,Eli Lilly and Company,IN,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,149.49,04/27/2020,In-kind items and services,,,,,,,No,No,"A RANDOMIZED, OPEN-LABEL, PHASE 3 STUDY OF ABEMACICLIB COMBINED WITH STANDARD ADJUVANT ENDOCRINE THERAPY VERSUS STANDARD ADJUVANT ENDOCRINE THERAPY ALONE IN PATIENTS WITH HIGH RISK, NODE POSITIVE, EARLY STAGE, HORMONE RECEPTOR POSITIVE, HUMAN EPIDERMAL RECEPTOR 2 NEGATIVE, BREAST CANCER",No,728720095,2020,01/20/2023,NCT03155997,https://clinicaltrials.gov/ct2/show/NCT03155997,"The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor"
6896,UNCHANGED,Covered Recipient Physician,,,,,78940.0,1730281452.0,DAVID,,SCOTT,III,23201 MERRICK BLVD,,LAURELTON,NY,11413,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology,,,,,,NY,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Eli Lilly and Company,100000000088,Eli Lilly and Company,IN,United States,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,28.24,02/27/2020,In-kind items and services,,,,,,,No,No,"A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-ARM, PLACEBO-CONTROLLED MAINTENANCE STUDY OF MIRIKIZUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS (LUCENT 2)",No,728717711,2020,01/20/2023,NCT03524092,https://clinicaltrials.gov/ct2/show/NCT03524092,"The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor"
326,UNCHANGED,Covered Recipient Teaching Hospital,,190005.0,8938.0,UNIVERSITY MEDICAL CTR. AT NEW ORLEA,,,,,,,2000 Canal St,,New Orleans,LA,70112,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,1183133.0,1801854781.0,JYOTSNA,,FULORIA,,1514 JEFFERSON HWY,1514 JEFFERSON HWY,NEW ORLEANS,LA,70121-2429,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,,,,,,LA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Merck Sharp & Dohme Corporation,100000000053,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Drug,ONCOLOGY,LENVIMA,62856-712-30,,,,,,,,,,,,,,,,,,,,,,,,,,2.4,07/09/2020,In-kind items and services,,,,,,,No,No,"A Phase 3 Multicenter, Randomized, Double-blinded, Active-controlled, Clinical Study to Evaluate the Safety and Efficacy of Lenvatinib E7080,MK-7902 with Pembrolizumab MK-3475 in Combination with Transarterial Chemoembolization TACE Versus TACE in Participants with Incurable,Non-metastatic Hepatocellular Carcinoma LEAP-012",No,740791671,2020,01/20/2023,,,Equipment or non-drug supplies provided to a clinical study site.
2099,UNCHANGED,Covered Recipient Physician,,,,,289088.0,1386738938.0,BARRY,J,REINER,,1001 PINE HEIGHTS AVE,STE 202,BALTIMORE,MD,21229,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Endocrinology,,,,,,MD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Novo Nordisk Inc,100000000163,Novo Nordisk AS,,Denmark,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4.5,10/26/2020,In-kind items and services,,,,,,,No,No,NN9536-4451,No,742452561,2020,01/20/2023,,,
1977,UNCHANGED,Covered Recipient Teaching Hospital,,450076.0,9670.0,Ut Md Anderson Cancer Center,,,,,,,1515 Holcombe Blvd,,Houston,TX,77030,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,1095756.0,1720399074.0,XIUNING,,LE,,330 BROOKLINE AVE.,,BOSTON,MA,02215,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,,,,,,MA,TX,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"EMD Serono, Inc.",100000000127,"EMD Serono, Inc.",MA,United States,Yes,Non-Covered,Drug,Oncology,Tepotinib,,,,,,,,,,,,,,,,,,,,,,,,,,,47.0,01/10/2020,Cash or cash equivalent,,,,,,,No,No,MS200095-0022,No,749585325,2020,01/20/2023,,,
6920,UNCHANGED,Covered Recipient Physician,,,,,653476.0,1184859175.0,CLIFTON,STEVE,HUANG,,1500 COOPER ST,,FORT WORTH,TX,76104,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Gastroenterology,,,,,,TX,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Eli Lilly and Company,100000000088,Eli Lilly and Company,IN,United States,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,105.66,06/15/2020,In-kind items and services,,,,,,,No,No,"MULTICENTER, OPEN-LABEL PK STUDY OF MIRIKIZUMAB IN PEDIATRIC PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS",No,728718193,2020,01/20/2023,NCT04004611,https://clinicaltrials.gov/ct2/show/NCT04004611,"The amount reported represents either an aggregate of cash payments -e.g. clinical study services, reimbursements for expenses or pass-through costs- or an aggregate of in-kind value -e.g. supplies, equipment- provided by Lilly or by a third party vendor in connection with clinical studies during the reporting period.  For available study details, please visit clinicaltrials.gov."
115,UNCHANGED,Covered Recipient Teaching Hospital,,230236.0,9149.0,Metropolitan Hospital,,,,,,,5900 BYRON CENTER AVE SW,,WYOMING,MI,49519,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,192983.0,1255312302.0,MATTHEW,W.,SEVENSMA,,5900 BYRON CENTER AVE SW,,WYOMING,MI,49519,United States,,,Doctor of Osteopathy,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease,,,,,,MI,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BIOTRONIK INC.,100000010579,BIOTRONIK INC.,OR,United States,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,165.0,01/08/2020,Cash or cash equivalent,,,,,,,No,No,BIO-LIBRA,No,751906883,2020,01/20/2023,,,
9948,UNCHANGED,Covered Recipient Teaching Hospital,,450076.0,9670.0,UT MD ANDERSON CANCER CENTER,,,,,,,1515 Holcombe Blvd,,Houston,TX,77030,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,175298.0,1861495343.0,JOHN,,SARANTOPOULOS,,7979 WURZBACH RD,7979 WURZBACH RD,SAN ANTONIO,TX,78229-4427,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,,,,,,TX,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Merck Sharp & Dohme Corporation,100000000053,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Biological,ONCOLOGY,KEYTRUDA,0006-3029-02,,,,,,,,,,,,,,,,,,,,,,,,,,97.56,04/24/2020,Cash or cash equivalent,,,,,,,No,No,"A Phase III, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Pembrolizumab MK-3475 as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy",No,740708309,2020,01/20/2023,,,
818,UNCHANGED,Covered Recipient Teaching Hospital,,103300.0,9456.0,Johns Hopkins All Childrens Hospita,,,,,,,501 6th Avenue South  6500002504,,St. Petersburg,FL,33701,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,273555.0,1043257215.0,ALFRED,,ASANTE KORANG,,501 6TH ST S,"2ND FLR, DEPT 7130",ST PETERSBURG,FL,33701-4630,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Cardiology,,,,,,FL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Daiichi Sankyo Inc.,100000000195,Daiichi Sankyo Inc.,NJ,United States,Yes,Covered,Drug,Thrombosis,Savaysa,65597-201-10,,,,,,,,,,,,,,,,,,,,,,,,,,22.94,10/08/2020,Cash or cash equivalent,,,,,,,No,No,DU176b-C-U313,No,745483419,2020,01/20/2023,,,
9651,UNCHANGED,Covered Recipient Teaching Hospital,,230046.0,9198.0,UNIV OF MI HOSPITALS & HLTH CTRS,,,,,,,1500 EAST MEDICAL CENTER DRIVE,,ANN ARBOR,MI,48109,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,1261230.0,1568607653.0,TYCEL,JOVELLE,PHILLIPS,,1500 E MEDICAL CENTER DR,,ANN ARBOR,MI,48109,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology,,,,,,MI,OH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Genentech, Inc.",100000000089,"Genentech, Inc.",CA,United States,Yes,Covered,Biological,BioOncology/Immunology,Rituxan,50242-053-06,,Covered,Biological,Immunology,Actemra,50242-137-01,,Covered,Biological,BioOncology,POLIVY,50242-105-01,,Non-Covered,Drug,None,Non-Covered Product,,,,,,,,,175583.34,11/23/2020,Cash or cash equivalent,,,,,,,No,No,PH1B 2 TDB CHP POLA IN NHL FOR DOSE ESCALATION PH1B FOLLOWED BY 1L DLBCL FOR EXPANSION PH2,No,743021101,2020,01/20/2023,,,
2844,UNCHANGED,Covered Recipient Teaching Hospital,,50239.0,9934.0,ADVENTIST HEALTH GLENDALE,,,,,,,1509 WILSON TER,,GLENDALE,CA,91206,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,81835.0,1801003686.0,MIKAYEL,,GRIGORYAN,,1451 E CHEVY CHASE DR,,GLENDALE,CA,91206,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Vascular Neurology,,,,,,CA,GA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Genentech, Inc.",100000000089,"Genentech, Inc.",CA,United States,Yes,Non-Covered,Drug,None,Non-Covered Product,,,,,,,,,,,,,,,,,,,,,,,,,,,3517.42,07/23/2020,Cash or cash equivalent,,,,,,,No,No,TENECTEPLASE IN STROKE PATIENTS BETWEEN 4 5 AND 24 HOURS,No,742992259,2020,01/20/2023,,,
9755,UNCHANGED,Covered Recipient Physician,,,,,156306.0,1437250859.0,KEVIN,B.,KAISERMAN,,3400 Lomita Blvd,Ste 209,Torrance,CA,90505,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Endocrinology,,,,,,CA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Medtronic MiniMed, Inc.",100000010391,"Medtronic MiniMed, Inc.",MN,United States,Yes,Covered,Device,Continuous Glucose Monitoring,Guardian Sensor 3,,,,,,,,,,,,,,,,,,,,,,,,,,,7433.0,02/05/2020,Cash or cash equivalent,,,,,,,No,No,CIP324 Zeus Pivotal,No,728046533,2020,01/20/2023,,,
3625,UNCHANGED,Covered Recipient Teaching Hospital,,50599.0,9919.0,UC DAVIS MEDICAL CENTER,,,,,,,2315 Stockton Blvd,,Sacramento,CA,95817,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,66405.0,1477651222.0,KAREN,L,KELLY,,2279 45TH STREET,,SACRAMENTO,CA,95817-2229,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,,,,,,CA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,AbbVie Inc.,100000000204,AbbVie Inc.,IL,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,34909.56,02/28/2020,Cash or cash equivalent,,,,,,,No,No,M14-006,No,721141019,2020,01/20/2023,NCT01946074,,
2654,UNCHANGED,Covered Recipient Teaching Hospital,,230297.0,8803.0,KARMANOS CANCER HOSPITAL,,,,,,,4100 John R St,,Detroit,MI,48201,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,273363.0,1013960384.0,AMMAR,,SUKARI,,4100 JOHN R,4100 JOHN R,DETROIT,MI,48201-2013,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,,,,,,MI,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Merck Sharp & Dohme Corporation,100000000053,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Biological,ONCOLOGY,KEYTRUDA,0006-3029-02,,,,,,,,,,,,,,,,,,,,,,,,,,12.1,01/09/2020,In-kind items and services,,,,,,,No,No,"A Phase III, Randomized, Open-label Study to Evaluate Pembrolizumab as Neoadjuvant Therapy and in Combination With Standard of Care as Adjuvant Therapy for Stage III-IVA Resectable Locoregionally Advanced Head and Neck Squamous Cell Carcinoma LA HNSCC",No,740733275,2020,01/20/2023,,,Equipment or non-drug supplies provided to a clinical study site.
3660,UNCHANGED,Covered Recipient Physician,,,,,801942.0,1417078221.0,NEERAJ,,AGARWAL,,2000 CIRCLE OF HOPE DR STE 2100,,SALT LAKE CITY,UT,84112,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,,,,,,UT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Pfizer Inc.,100000000286,PFIZER INC.,NY,United States,Yes,Covered,Drug,ONCOLOGY,TALZENNA,0069-0296-30,,,,,,,,,,,,,,,,,,,,,,,,,,620.0,02/15/2020,In-kind items and services,,,,,,,No,No,TALAZOPARIB CLINICAL PUBLICATION PROGRAM,No,742856537,2020,01/20/2023,,,No payment was made directly to this author. This is a fair market value payment for editorial or medical writing services paid to a 3rd-party vendor to assist with the development of a publication.
4740,UNCHANGED,Covered Recipient Teaching Hospital,,54144.0,9918.0,LANGLEY PORTER PSYCHIATRIC HOSPITAL,,,,,,,405 PARNASUS,,SAN FRANCISCO,CA,94143,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,183398.0,1033176581.0,HOPE,S,RUGO,,1825 4TH ST FL 3,,SAN FRANCISCO,CA,94143,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,,,,,,CA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Pfizer Inc.,100000000286,PFIZER INC.,NY,United States,Yes,Covered,Drug,ONCOLOGY,TALZENNA,0069-0296-30,,,,,,,,,,,,,,,,,,,,,,,,,,26515.9,03/17/2020,Cash or cash equivalent,,,,,,,No,No,A PHASE 3 OPENLABEL RANDOMIZED PARALLEL2ARMMULTICENTER STUDY OF TALAZOPARIBBMN 673 VERSUS PHYSICIANS CHOICE IN GERMLINE BRCA MUTATION SUBJECTS WITH LOCALLY ADVANCED ANDOR METASTATIC BREAST CANCER WHO HAVE RECEIVED PRIOR CHEMOTHERAPY REGIMENS FOR METASTATIC DISEASE,No,742886545,2020,01/20/2023,,,
6367,UNCHANGED,Covered Recipient Teaching Hospital,,140119.0,9094.0,Rush University Medical Center,,,,,,,1653 W Congress Pkwy,,Chicago,IL,60612,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,801042.0,1376597625.0,Mark,Andrew,Yoder,,1725 W Harrison St,Pob 054,Chicago,IL,60612-3841,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease,,,,,,IL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,United Therapeutics Corporation,100000010739,United Therapeutics Corporation,NC,United States,Yes,Covered,Drug,PAH,TYVASO,66302-206-01,,,,,,,,,,,,,,,,,,,,,,,,,,7081.1,02/26/2020,Cash or cash equivalent,,,,,,,No,No,A MULTICENTER RANDOMIZED DOUBLE-BLINDED PLACEBO-CONTROLLED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF INHALED TREPROSTINIL IN SUBJECTS WITH PULMONARY HYPERTENSION DUE TO PARENCHYMAL LUNG DISEASE,No,752561251,2020,01/20/2023,NCT02630316,,
2383,UNCHANGED,Covered Recipient Physician,,,,,1160394.0,1992972897.0,ALEXANDRA,,DRAKAKI,,2020 SANTA MONICA BLVD SUITE 600,,SANTA MONICA,CA,90404,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine,,,,,,CA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Genentech, Inc.",100000005656,F. Hoffmann-La Roche AG,,Switzerland,Yes,Covered,Biological,BioOncology,Tecentriq,50242-917-01,,,,,,,,,,,,,,,,,,,,,,,,,,3258.36,09/30/2020,In-kind items and services,,,,,,,No,No,"Association of baseline systemic corticosteroid use with short- and long-term outcomes in patients with advanced non-small cell lung cancer, melanoma, or urothelial carcinoma receiving cancer immunotherapy in real-world US oncology practice",No,742972203,2020,01/20/2023,,,
9435,UNCHANGED,Covered Recipient Teaching Hospital,,363302.0,9040.0,RAINBOW BABIES & CHILDRENS HOSPITAL,,,,,,,11100 Euclid Ave,,Cleveland,OH,44106,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,1388267.0,1336303817.0,LELAND,L,METHENY,III,11100 EUCLID AVE,,CLEVELAND,OH,44106,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,,,,,,OH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Pfizer Inc.,100000000286,PFIZER INC.,NY,United States,Yes,Covered,Biological,ONCOLOGY,BESPONSA,0008-0100-01,,,,,,,,,,,,,,,,,,,,,,,,,,30000.0,09/28/2020,Cash or cash equivalent,,,,,,,No,No,INOTUZUMAB OZOGAMICIN POSTTRANSPLANT FOR ACUTE LYMPHOCYTIC LEUKEMIA,No,742901093,2020,01/20/2023,,,
3539,UNCHANGED,Covered Recipient Teaching Hospital,,330167.0,8695.0,Nyu Winthrop Hospital,,,,,,,259 1st Street,,Mineola,NY,11501,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,29407.0,1649261264.0,DAVID,M,CHARYTAN,,462 1ST AVE,,NEW YORK,NY,10016,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology,,,,,,MA,NY,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Novo Nordisk Inc,100000000163,Novo Nordisk AS,,Denmark,Yes,Covered,Drug,Diabetes,Ozempic,0169-4132-12,,,,,,,,,,,,,,,,,,,,,,,,,,72.0,08/25/2020,In-kind items and services,,,,,,,No,No,NN9535-4321,No,742310363,2020,01/20/2023,,,
6085,UNCHANGED,Covered Recipient Physician,,,,,62644.0,1376572784.0,ANNE,L.,PETERS,,9033 Wilshire Blvd Ste 406,,Beverly Hills,CA,90211,United States,,,Medical Doctor,,,,,,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",,,,,,CA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Sanofi and Genzyme US Companies,100000000076,SANOFI-AVENTIS U.S. LLC,NJ,United States,Yes,Covered,Biological,Endocrinology,TOUJEO,0024-5869-03,,,,,,,,,,,,,,,,,,,,,,,,,,574.29,06/12/2020,In-kind items and services,,,,,,,No,No,"Multinational, cross-sectional, observational study to describe glycemic control and quality of life for type 1 diabetic adult patients",No,744030485,2020,01/20/2023,,,
7424,UNCHANGED,Covered Recipient Teaching Hospital,,330154.0,8722.0,Memorial Hospital For Cancer And All,,,,,,,1275 York Ave,,New York,NY,10065,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,228930.0,1053473983.0,ANTHONY,R,MATO,,136 Mountainview Blvd,,Basking Ridge,NJ,07920,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,,,,,,NJ,NY,PA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Adaptive Biotechnologies Corporation,100000486814,Adaptive Biotechnologies Corporation,WA,United States,Yes,Covered,Device,B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA,clonoSEQ,,,,,,,,,,,,,,,,,,,,,,,,,,,450.0,12/22/2020,In-kind items and services,Patient Care,,,,,,No,No,19-395,No,752361045,2020,01/20/2023,,,
3854,UNCHANGED,Covered Recipient Teaching Hospital,,363300.0,8988.0,CHILDRENS HOSPITAL MEDICAL CENTER,,,,,,,3333 Burnet Ave,,Cincinnati,OH,45229,United States,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"PTC Therapeutics, Inc.",100000191753,"PTC Therapeutics, Inc.",NJ,United States,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,41271.0,01/24/2020,Cash or cash equivalent,,,,,,,No,No,DRUG INTERACTION STUDY WITH PHOTONS - DR. DRISSI,No,748308929,2020,01/20/2023,,,
3916,UNCHANGED,Covered Recipient Physician,,,,,165426.0,1659337855.0,JAMES,W,WHELESS,,848 ADAMS AVE.,STE. L400,MEMPHIS,TN,38105,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology with Special Qualifications in Child Neurology,,,,,,TN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"UCB, Inc.",100000000073,"UCB, Inc.",GA,United States,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2300.0,07/21/2020,In-kind items and services,,,,,,,No,No,"Safety and efficacy of midazolam nasal spray for the treatment of intermittent bouts of increased seizure activity in the epilepsy monitoring unit A double-blind, randomized, placebo-controlled trial",No,746123371,2020,01/20/2023,,,
2587,UNCHANGED,Covered Recipient Teaching Hospital,,390111.0,8882.0,HOSPITAL OF THE UNIV OF PENNA,,,,,,,3400 SPRUCE ST,,PHILADELPHIA,PA,19104,United States,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Genentech, Inc.",100000000089,"Genentech, Inc.",CA,United States,Yes,Covered,Biological,Immunology,OCREVUS,50242-150-01,,,,,,,,,,,,,,,,,,,,,,,,,,197360.0,09/28/2020,Cash or cash equivalent,,,,,,,No,No,MNT OBOE,No,743002133,2020,01/20/2023,,,
3973,UNCHANGED,Covered Recipient Teaching Hospital,,440039.0,9077.0,Vanderbilt University Medical Center,,,,,,,1211 MEDICAL CENTER DRIVE,,NASHVILLE,TN,37232,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,1269688.0,1851488985.0,KATHRYN,M.,DAHIR,,1215 21st Ave S Ste 8210,,Nashville,TN,37232,United States,,,Medical Doctor,,,,,,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",,,,,,TN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Alexion Pharmaceuticals, Inc.",100000005462,"Alexion Pharmaceuticals, Inc.",MA,United States,Yes,Covered,Drug,Endocrinology,Strensiq,25682-010-12,,,,,,,,,,,,,,,,,,,,,,,,,,634.0,05/14/2020,Cash or cash equivalent,,,,,,,No,No,"An Observational, Longitudinal, Prospective, Long-Term Registry Of Patients With Hypophosphatasia (HPP)",No,724598863,2020,01/20/2023,NCT02306720,,
2652,UNCHANGED,Covered Recipient Teaching Hospital,,220071.0,8644.0,Massachusetts General Hospital,,,,,,,55 Fruit St,Bulfinch 360,Boston,MA,02114,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,1020715.0,1083908099.0,CHRISTOPHER,J,STAPLETON,,912 S WOOD ST # MC799,,CHICAGO,IL,60612,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Neurological Surgery,,,,,,IL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Penumbra, Inc.",100000010583,"Penumbra, Inc.",CA,United States,Yes,Covered,Device,Neurointervention,Penumbra SMART Coil,,,,,,,,,,,,,,,,,,,,,,,,,,,1462.5,12/30/2020,Cash or cash equivalent,,,,,,,No,No,SURF,No,752348959,2020,01/20/2023,,,
7962,UNCHANGED,Covered Recipient Teaching Hospital,,450076.0,9670.0,Ut Md Anderson Cancer Center,,,,,,,1515 HOLCOMBE BLVD,,HOUSTON,TX,77030,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,58875.0,1306932074.0,FUNDA,,MERIC-BERNSTAM,,1400 HOLCOMBE BLVD,UNIT 0455,HOUSTON,TX,77030-4008,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Surgery|Surgical Oncology,,,,,,TX,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Seagen Inc.,100000000279,Seagen Inc.,WA,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,55268.16,08/04/2020,Cash or cash equivalent,,,,,,,No,No,A Study of SGN-CD228A in Advanced Solid Tumors,No,733457029,2020,01/20/2023,NCT04042480,,
6659,UNCHANGED,Covered Recipient Teaching Hospital,,160058.0,9253.0,UNIVERSITY OF IOWA HOSP & CLINICS,,,,,,,200 Hawkins Dr,,Iowa City,IA,52242,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,616218.0,1891770616.0,MARK,W,KARWAL,,200 HAWKINS DR,200 HAWKINS DR,IOWA CITY,IA,52242-1009,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,,,,,,IA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Merck Sharp & Dohme Corporation,100000000053,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Biological,ONCOLOGY,KEYTRUDA,0006-3029-02,,,,,,,,,,,,,,,,,,,,,,,,,,200.0,12/03/2020,Cash or cash equivalent,,,,,,,No,No,A Phase 2 Study of Pembrolizumab MK-3475 as Monotherapy in Subjects with Advanced Hepatocellular Carcinoma KEYNOTE-224,No,740812255,2020,01/20/2023,,,
917,UNCHANGED,Covered Recipient Teaching Hospital,,260141.0,9266.0,Univ Of Missouri Health Care,,,,,,,One Hospital Drive,,Columbia,MO,65212,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,733620.0,1992971550.0,ESPERANZA,,FONT-MONTGOMERY,,404 N KEENE ST STE 101,,COLUMBIA,MO,65201,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Pediatrics,,,,,,MO,WI,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BioMarin Pharmaceutical Inc.,100000010405,BioMarin Pharmaceutical Inc.,CA,United States,Yes,Covered,Drug,PKU,Palynziq,68135-058-90,,,,,,,,,,,,,,,,,,,,,,,,,,166.67,01/06/2020,Cash or cash equivalent,,,,,,,No,No,An Open-label Extension Study to Evaluate the Safety and Efficacy of Subcutaneous Injections of Pegvaliase  40 mgday Dose) in Adults with Phenylketonuria,No,740700147,2020,01/20/2023,,,
4735,UNCHANGED,Covered Recipient Teaching Hospital,,500054.0,9130.0,Prov Sacred Heart Medical Center,,,,,,,101 W 8th Ave,,Spokane,WA,99204,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,124125.0,1740399492.0,KATHRINE,R,TUTTLE,,105 W 8th Ave,Ste 1000,SPOKANE,WA,99204,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology,,,,,,WA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Travere Therapeutics, Inc.",100000061305,"Travere Therapeutics, Inc.",CA,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2427.0,11/19/2020,Cash or cash equivalent,Other,,,,,,No,No,021FSGS16010,No,734746513,2020,01/20/2023,,,
7508,UNCHANGED,Covered Recipient Teaching Hospital,,220162.0,8640.0,Dana-Farber Cancer Institute,,,,,,,450 Brookline Ave,,Boston,MA,02215,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,180753.0,1992712178.0,PASI ANTERO,,JANNE,,44 BINNEY ST,DANA FARBER CANCER INSTITUTE,BOSTON,MA,02115,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,,,,,,MA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Daiichi Sankyo Inc.,100000000195,Daiichi Sankyo Inc.,NJ,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,26.85,11/09/2020,Cash or cash equivalent,,,,,,,No,No,U31402-A-U102,No,745484205,2020,01/20/2023,,,
3082,UNCHANGED,Covered Recipient Teaching Hospital,,310001.0,8837.0,HACKENSACK UNIVERSITY MEDICAL CENTER,,,,,,,30 Prospect Ave,,Hackensack,NJ,07601,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,246880.0,1457310815.0,DAVID,S,SIEGEL,,92 2ND ST,92 2ND ST,HACKENSACK,NJ,07601-2105,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,,,,,,DC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Merck Sharp & Dohme Corporation,100000000053,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Drug,ONCOLOGY,ZOLINZA,0006-0568-40,,,,,,,,,,,,,,,,,,,,,,,,,,180115.2,03/11/2020,In-kind items and services,,,,,,,No,No,"A Phase I,II study of carfilzomib, lenalidomide, vorinostat, and dexamethasone in relapsed and,or refractory multiple myeloma",No,740826839,2020,01/20/2023,,,Study drug provided for an investigator-initiated clinical study.
9526,UNCHANGED,Covered Recipient Teaching Hospital,,450076.0,9670.0,Ut Md Anderson Cancer Center,,,,,,,1515 Holcombe Blvd,,Houston,TX,77030,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,1095756.0,1720399074.0,XIUNING,,LE,,330 BROOKLINE AVE.,,BOSTON,MA,02215,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,,,,,,MA,TX,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"EMD Serono, Inc.",100000000127,"EMD Serono, Inc.",MA,United States,Yes,Non-Covered,Drug,Oncology,Tepotinib,,,,,,,,,,,,,,,,,,,,,,,,,,,47.0,01/10/2020,Cash or cash equivalent,,,,,,,No,No,MS200095-0022,No,749585355,2020,01/20/2023,,,
2061,UNCHANGED,Covered Recipient Teaching Hospital,,140010.0,9083.0,NORTHSHORE UNIVERSITY HEALTHSYSTEM,,,,,,,2650 Ridge Ave,,Evanston,IL,60201,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,726324.0,1740349695.0,BRUCE,EARL,BROCKSTEIN,,2650 RIDGE AVE,KELLOGG CANCER CENTER,EVANSTON,IL,60201,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,,,,,,IL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Regeneron Pharmaceuticals, Inc.",100000000069,"Regeneron Pharmaceuticals, Inc.",NY,United States,Yes,Covered,Biological,ONCOLOGY,LIBTAYO,61755-008-01,,,,,,,,,,,,,,,,,,,,,,,,,,1100.0,07/08/2020,Cash or cash equivalent,,,,,,,No,No,CEMIPLIMAB SURVIVORSHIP EPIDEMIOLOGY (CASE) STUDY,No,724445065,2020,01/20/2023,NCT03836105,,
9130,UNCHANGED,Covered Recipient Physician,,,,,709466.0,1144255746.0,CHRYSALYNE,D,SCHMULTS,,1153 CENTRE ST STE 4349,,JAMAICA PLAIN,MA,02130-3446,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Dermatology|MOHS-Micrographic Surgery,,,,,,MA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Regeneron Pharmaceuticals, Inc.",100000000069,"Regeneron Pharmaceuticals, Inc.",NY,United States,Yes,Covered,Biological,ONCOLOGY,LIBTAYO,61755-008-01,,,,,,,,,,,,,,,,,,,,,,,,,,25.63,12/30/2020,In-kind items and services,,,,,,,No,No,LIBTAYO CLINICAL PUBLICATION PROGRAM,No,724436591,2020,01/20/2023,,,"The transfer of value captured herein was not a distribution of cash or goods. Instead, this report captures the provision of editorial assistance provided to the authors of the underlying publication. The value of this assistance was divided among the authors of the publication."
4054,UNCHANGED,Covered Recipient Teaching Hospital,,210011.0,9340.0,St. Agnes Hospital,,,,,,,900 CATON AVE,,BALTIMORE,MD,21229,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,20019.0,1457310856.0,CAROLE,B.,MILLER,,900 CATON AVE,STE 60,BALTIMORE,MD,21229,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,,,,,,MD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Incyte Corporation,100000000263,Incyte Corporation,DE,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,30.4,03/09/2020,Cash or cash equivalent,,,,,,,No,No,"A Double Blind, Double Dummy Phase 2 Randomized Study to Evaluate the Efficacy and Safety of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET 272)",No,744297193,2020,01/20/2023,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
4206,UNCHANGED,Covered Recipient Physician,,,,,573193.0,1386628923.0,CHARLTON,,OWENSBY,,2525 COURT DR,SUITE 150,GASTONIA,NC,28054-2140,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Preventive Medicine|Occupational Medicine,,,,,,NC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Indivior Inc.,100000136552,Indivior Inc.,VA,United States,Yes,Covered,Drug,OUD,BUPRENORPHINE AND NALOXONE,0781-7216-64,,Covered,Drug,OUD,SUBOXONE,12496-1202-3,,,,,,,,,,,,,,,,,,,,150.0,07/21/2020,Cash or cash equivalent,,,,,,,No,No,"Quantitative Testing of Prescriber/Pharmacist Knowledge, Attitudes and Behavior about SUBOXONE (buprenorphine and naloxone) Sublingual Film (CIII) or the Authorized Generic of SUBOXONE Sublingual Film (CIII) Safety and Use Information",No,752718075,2020,01/20/2023,,,
6,UNCHANGED,Covered Recipient Teaching Hospital,,360137.0,9041.0,Uh Cleveland Medical Center,,,,,,,DEPT 781686 P O BOX 78000,,DETROIT,MI,48278-1686,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,91322.0,1023261476.0,MELINDA,,LAWRENCE,,11100 EUCLID AVE,,CLEVELAND,OH,44106,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Anesthesiology,,,,,,OH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BOSTON SCIENTIFIC CORPORATION,100000005674,BOSTON SCIENTIFIC CORPORATION,MA,United States,Yes,Covered,Device,PAIN MANAGEMENT,SPECTRA WAVEWRITER,,,,,,,,,,,,,,,,,,,,,,,,,,,7878.0,07/20/2020,Cash or cash equivalent,,,,,,,No,No,VERITAS,No,730131139,2020,01/20/2023,NCT03251937,,
9244,UNCHANGED,Covered Recipient Physician,,,,,948211.0,1548491459.0,John,,Avolio,,506 S MAIN ST,#2103,ZELIENOPLE,PA,16063,United States,,,Doctor of Dentistry,,,,,,Dental Providers|Dentist|General Practice,,,,,,PA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Align Technology, Inc.",100000005613,"Align Technology, Inc.",CA,United States,Yes,Covered,Device,Orthodontics,Invisalign,,,,,,,,,,,,,,,,,,,,,,,,,,,20.0,11/19/2020,Cash or cash equivalent,Other,,,,,,No,No,Online Research Survey,No,752862171,2020,01/20/2023,,,
8817,UNCHANGED,Covered Recipient Teaching Hospital,,300003.0,8626.0,Mary Hitchcock Memorial Hosp,,,,,,,ONE MEDICAL CENTER DR,,LEBANON,NH,03756,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,1048629.0,1073536504.0,GARY,N.,SCHWARTZ,,1 MEDICAL CENTER DR,,LEBANON,NH,03756,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,,,,,,NH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Seagen Inc.,100000000279,Seagen Inc.,WA,United States,Yes,Covered,Drug,Oncology,TUKYSA,51144-001-60,,,,,,,,,,,,,,,,,,,,,,,,,,5200.0,09/25/2020,Cash or cash equivalent,,,,,,,No,No,"Phase 2 Randomized, Double-Blinded, Controlled Study of Tucatinib",No,733445685,2020,01/20/2023,NCT02614794,https://clinicaltrials.gov/ct2/show/NCT02614794,
7287,UNCHANGED,Covered Recipient Teaching Hospital,,143300.0,9092.0,ANN & ROBERT H. LURIE CHILDRENS HOS,,,,,,,225 E Chicago Ave  44,,Chicago,IL,60611,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,31005.0,1699743088.0,BARBARA,K,BURTON,,2300 CHILDRENS PLAZA,,CHICAGO,IL,60614,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Medical Genetics|Clinical Genetics (M.D.),,,,,,IL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Takeda Pharmaceuticals U.S.A., Inc.",100000000337,"Takeda Pharmaceuticals U.S.A., Inc.",IL,United States,Yes,Covered,Biological,GENETIC DISEASE,ELAPRASE,54092-700-01,,,,,,,,,,,,,,,,,,,,,,,,,,10483.0,09/29/2020,Cash or cash equivalent,,,,,,,No,No,AN OPEN LABEL EXTENSION OF STUDY HGT-HIT-094 EVALUATING LONG TERM SAFETY AND CLINICAL OUTCOMES OF INTRATHECAL IDURSULFASE ADMINISTERED IN CONJUNCTION WITH ELAPRASE IN PATIENTS WITH HUNTER SYNDROME AND COGNITIVE IMPAIRMENT,No,737059991,2020,01/20/2023,,,
12,UNCHANGED,Covered Recipient Teaching Hospital,,100007.0,9460.0,Adventhealth Orlando,,,,,,,601 E ROLLINS ST,,ORLANDO,FL,32803,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,16069.0,1346247970.0,JOSE,HERNANDO,ARIAS,,1613 N MILLS AVE,,ORLANDO,FL,32803,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Interventional Cardiology,,,,,,FL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BIOTRONIK INC.,100000010579,BIOTRONIK INC.,OR,United States,Yes,Covered,Device,Cardiology/Vascular Diseases,Orsiro,,,,,,,,,,,,,,,,,,,,,,,,,,,750.0,08/25/2020,Cash or cash equivalent,,,,,,,No,No,BIOFLOW-V,No,751910469,2020,01/20/2023,,,
1919,UNCHANGED,Covered Recipient Teaching Hospital,,310001.0,8837.0,HACKENSACK UNIVERSITY MEDICAL CENTER,,,,,,,30 Prospect Ave,,Hackensack,NJ,07601,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,79884.0,1770544504.0,ANDREW,L,PECORA,,92 2ND ST,92 2ND ST,HACKENSACK,NJ,07601-2191,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,,,,,,DC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Merck Sharp & Dohme Corporation,100000000053,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Biological,ONCOLOGY,KEYTRUDA,0006-3029-02,,,,,,,,,,,,,,,,,,,,,,,,,,11250.0,03/24/2020,Cash or cash equivalent,,,,,,,No,No,"A Multicenter, Open label, Phase III Extension Trial to Study the Long-term Safety and Efficacy in Participants with Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab Trial",No,740738655,2020,01/20/2023,,,
5813,UNCHANGED,Covered Recipient Teaching Hospital,,380009.0,9844.0,Ohsu Hospital And Clinics,,,,,,,3181 SW SAM JACKSON PARK RD,,PORTLAND,OR,97239,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,643978.0,1851473060.0,CHARLES,D.,LOPEZ,,3181 SW SAM JACKSON PARK RD,# L586,PORTLAND,OR,97239,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,,,,,,OR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Incyte Corporation,100000000263,Incyte Corporation,DE,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1420.0,03/12/2020,Cash or cash equivalent,,,,,,,No,No,A Pilot Study of Ruxolitinib in Secondary Hemophagocytic Syndrome,No,744275423,2020,01/20/2023,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
1906,UNCHANGED,Covered Recipient Teaching Hospital,,300034.0,8627.0,Catholic Medical Center,,,,,,,100 MCGREGOR ST,,MANCHESTER,NH,03102-3730,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,11126.0,1235178187.0,HYUN-HO JAMIE,,KIM,,100 MCGREGOR ST,,MANCHESTER,NH,03102-3730,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology,,,,,,NH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BOSTON SCIENTIFIC CORPORATION,100000005674,BOSTON SCIENTIFIC CORPORATION,MA,United States,Yes,Covered,Device,CLINICAL TRIAL PRODUCT,CLINICAL TRIAL PRODUCT,,,,,,,,,,,,,,,,,,,,,,,,,,,5662.0,10/19/2020,Cash or cash equivalent,,,,,,,No,No,PINNACLE FLX,No,730124499,2020,01/20/2023,NCT02702271,,
8813,UNCHANGED,Covered Recipient Teaching Hospital,,53300.0,9900.0,Valley Childrens Hospital,,,,,,,9300 Valley Childrens Pl,,Madera,CA,93636,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,64932.0,1417995531.0,NEDIM,,CAKAN,,9300 VALLEY CHILDRENS PL,# FC13,MADERA,CA,93636,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Pediatrics,,,,,,CA,MI,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Novo Nordisk Inc,100000000163,Novo Nordisk AS,,Denmark,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3500.0,04/23/2020,Cash or cash equivalent,,,,,,,No,No,NN8640-4263,No,742445795,2020,01/20/2023,,,
4648,UNCHANGED,Covered Recipient Teaching Hospital,,220162.0,8640.0,Dana-Farber Cancer Institute,,,,,,,450 BROOKLINE AVE,,BOSTON,MA,02215,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,314270.0,1922086487.0,JACOB,P.,LAUBACH,,44 BINNEY ST,STE D1B30,BOSTON,MA,02115,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,,,,,,MA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Incyte Corporation,100000000263,Incyte Corporation,DE,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.54,03/09/2020,Cash or cash equivalent,,,,,,,No,No,GRAVITAS 309-A Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease,No,744295137,2020,01/20/2023,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
8883,UNCHANGED,Covered Recipient Teaching Hospital,,390111.0,8882.0,HOSPITAL OF THE UNIV OF PENNA,,,,,,,3400 Spruce St,,Philadelphia,PA,19104,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,302007.0,1669526851.0,MARK,TOMISLAV,OSTERMAN,,51 N 39TH ST,,PHILADELPHIA,PA,19104-2640,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology,,,,,,PA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Takeda Pharmaceuticals U.S.A., Inc.",100000000337,"Takeda Pharmaceuticals U.S.A., Inc.",IL,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,780.0,08/20/2020,Cash or cash equivalent,,,,,,,No,No,ENTYVIO (VEDOLIZUMAB) LONG-TERM SAFETY STUDY: AN INTERNATIONAL OBSERVATIONAL PROSPECTIVE COHORT STUDY COMPARING VEDOLIZUMAB TO OTHER BIOLOGIC AGENTS IN PATIENTS WITH ULCERATIVE COLITIS OR CROHN'S DISEASE,No,737062379,2020,01/20/2023,,,
4095,UNCHANGED,Covered Recipient Teaching Hospital,,50625.0,9924.0,CEDARS-SINAI MEDICAL CENTER,,,,,,,8700 Beverly Blvd,,Los Angeles,CA,90048,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,537046.0,1104914944.0,JIGNESH,KANUBHAI,PATEL,,8536 WILSHIRE BLVD,SUITE 302,BEVERLY HILLS,CA,90211,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease,,,,,,CA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Pfizer Inc.,100000000286,PFIZER INC.,NY,United States,Yes,Covered,Drug,CARDIOVASCULAR,VYNDAQEL,0069-8729-55,,,,,,,,,,,,,,,,,,,,,,,,,,975.0,03/19/2020,Cash or cash equivalent,,,,,,,No,No,A PHASE 3 MULTICENTER RANDOMIZED DOUBLEBLIND EXTENSION STUDY TO EVALUATE THE SAFETY OF DAILY ORAL DOSING OF TAFAMIDIS MEGLUMINE PF06291826 20 MG OR 80 MG IN SUBJECTS DIAGNOSED WITH TRANSTHYRETIN CARDIOMYOPATHY TTRCM,No,742911451,2020,01/20/2023,,,
5301,UNCHANGED,Covered Recipient Teaching Hospital,,50262.0,9958.0,RONALD REAGAN UCLA,,,,,,,757 Westwood Plz,,Los Angeles,CA,90095,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,126128.0,1790732543.0,FLAVIO,G,VINCENTI,,505 PARNASSUS AVE,505 PARNASSUS AVE,SAN FRANCISCO,CA,94143-2204,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine,,,,,,CA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Merck Sharp & Dohme Corporation,100000000053,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Drug,INFECTIOUS DISEASE,PREVYMIS,0006-5004-01,,,,,,,,,,,,,,,,,,,,,,,,,,221.55,03/09/2020,In-kind items and services,,,,,,,No,No,"A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Letermovir Versus Valganciclovir for the Prevention of Human Cytomegalovirus CMV Disease in Adult Kidney Transplant Recipients",No,740730717,2020,01/20/2023,,,Equipment or non-drug supplies provided to a clinical study site.
1804,UNCHANGED,Covered Recipient Teaching Hospital,,50599.0,9919.0,UC DAVIS MEDICAL CENTER,,,,,,,2315 STOCKTON BLVD,,SACRAMENTO,CA,95817,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,1056566.0,1356326060.0,CHRISTOPHER,P,EVANS,,UC DAVIS SCHOOL OF MEDICINE,4860 Y ST SUITE 3500,SACRAMENTO,CA,95817,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Urology,,,,,,CA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Pfizer Inc.,100000000286,PFIZER INC.,NY,United States,Yes,Covered,Drug,ONCOLOGY,XTANDI,0469-0125-99,,,,,,,,,,,,,,,,,,,,,,,,,,461.52,10/26/2020,Cash or cash equivalent,,,,,,,No,No,A PHASE 3 RANDOMIZED EFFICACY AND SAFETY STUDY OF ENZALUTAMIDE PLUS LEUPROLIDE ENZALUTAMIDE MONOTHERAPY AND PLACEBO PLUS LEUPROLIDE IN MEN WITH HIGHRISK NONMETASTATIC PROSTATE CANCER PROGRESSING AFTER DEFINITIVE THERAPY,No,742899409,2020,01/20/2023,,,
3172,UNCHANGED,Covered Recipient Physician,,,,,177889.0,1932181609.0,THEODORE,,WUN,,4501 X ST,UC DAVIS MEDICAL CENTER,SACRAMENTO,CA,95817,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,,,,,,CA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Pfizer Inc.,100000000286,PFIZER INC.,NY,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,940.0,09/25/2020,In-kind items and services,,,,,,,No,No,RIVIPANSEL CLINICAL PUBLICATION PROGRAM,No,742858669,2020,01/20/2023,,,No payment was made directly to this author. This is a fair market value payment for editorial or medical writing services paid to a 3rd-party vendor to assist with the development of a publication.
5785,UNCHANGED,Covered Recipient Teaching Hospital,,180103.0,9488.0,Baptist Health Lexington,,,,,,,1740 NICHOLASVILLE RD,,LEXINGTON,KY,40503,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,32625.0,1730127994.0,CRAIG,J.,MCCOTTER,,1720 NICHOLASVILLE RD STE 601,,LEXINGTON,KY,40503,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology,,,,,,KY,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BIOTRONIK INC.,100000010579,BIOTRONIK INC.,OR,United States,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,26.25,02/11/2020,Cash or cash equivalent,,,,,,,No,No,BIO-LIBRA,No,751912265,2020,01/20/2023,,,
5601,UNCHANGED,Covered Recipient Teaching Hospital,,390111.0,8882.0,Hospital Of The Univ Of Penna,,,,,,,3400 Spruce Street,,Philadelphia,PA,19104,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,527033.0,1740449487.0,JOSHUA,MICHAEL,BAUML,,3400 SPRUCE STREET,,PHILADELPHIA,PA,19104,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,,,,,,PA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Janssen Research & Development, LLC",100000005592,"Janssen Research & Development, LLC",NJ,United States,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,9185.0,04/06/2020,Cash or cash equivalent,,,,,,,No,No,"A Phase 1, First-in-Human, Open-Label, Dose Escalation Study of JNJ-61186372, a Human Bispecific EGFR and cMet Antibody, in Subjects with Advanced Non-Small Cell Lung Cancer",No,719475539,2020,01/20/2023,,,
5009,UNCHANGED,Covered Recipient Teaching Hospital,,440039.0,9077.0,Vanderbilt University Medical Center,,,,,,,1211 Medical Center Drive,,Nashville,TN,37232,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,67611.0,1487881041.0,LEORA,,HORN,,3601 TVC,,NASHVILLE,TN,37232,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,,,,,,TN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"EMD Serono, Inc.",100000000127,"EMD Serono, Inc.",MA,United States,Yes,Non-Covered,Drug,Oncology,Tepotinib,,,,,,,,,,,,,,,,,,,,,,,,,,,182.0,02/14/2020,Cash or cash equivalent,,,,,,,No,No,MS200095-0022,No,749591995,2020,01/20/2023,,,
3898,UNCHANGED,Covered Recipient Teaching Hospital,,500008.0,9831.0,University Of Washington Med Ctr,,,,,,,4300 ROOSEVELT WAY NE,,SEATTLE,WA,98105,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,21024.0,1457436289.0,CHRISTOPHER,HOOPER,GOSS,,1959 NE PACIFIC ST FL 1,,SEATTLE,WA,98195,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease,,,,,,WA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Boehringer Ingelheim Pharmaceuticals, Inc.",100000000234,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,United States,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12409.14,03/09/2020,Cash or cash equivalent,,,,,,,No,No,Phase 2 DR of ENaC inhibitor in adults adolescents,No,751190461,2020,01/20/2023,,,
2443,UNCHANGED,Covered Recipient Teaching Hospital,,460001.0,9907.0,Utah Valley Hospital,,,,,,,36 S STATE ST,,SALT LAKE CITY,UT,84111-1401,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,763213.0,1043288368.0,JEFFREY,,OSBORN,,5169 S COTTONWOOD ST,,SALT LAKE CITY,UT,84107-6770,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease,,,,,,ID,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BOSTON SCIENTIFIC CORPORATION,100000005674,BOSTON SCIENTIFIC CORPORATION,MA,United States,Yes,Covered,Device,TACHY,ACUITY,,,,,,,,,,,,,,,,,,,,,,,,,,,250.0,09/21/2020,Cash or cash equivalent,,,,,,,No,No,NAVIGATE X4 STUDY,No,730123029,2020,01/20/2023,NCT02071173,,
1299,UNCHANGED,Covered Recipient Teaching Hospital,,363300.0,8988.0,Childrens Hospital Medical Center,,,,,,,3333 Burnet Ave,,Cincinnati,OH,45229,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,925955.0,1770511883.0,PHILIPPE,F,BACKELJAUW,,3333 BURNET AVE,# 5006,CINCINNATI,OH,45229,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Endocrinology,,,,,,OH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Novo Nordisk Inc,100000000163,Novo Nordisk AS,,Denmark,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.25,08/14/2020,In-kind items and services,,,,,,,No,No,NN8640-4263,No,742376369,2020,01/20/2023,,,
7696,UNCHANGED,Covered Recipient Teaching Hospital,,140208.0,9089.0,Advocate Christ Hospital,,,,,,,4440 West 95th Street,,Oak Lawn,IL,60453,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,166551.0,1689655391.0,ANDREW,HENRY,VANBERGEN,,4440 W 95TH ST,,OAK LAWN,IL,60453-2600,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Cardiology,,,,,,IL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Janssen Research & Development, LLC",100000005592,"Janssen Research & Development, LLC",NJ,United States,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2421.69,05/22/2020,Cash or cash equivalent,,,,,,,No,No,"A Prospective, Open-Label, Active-Controlled Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Efficacy of Rivaroxaban for Thromboprophylaxis in Pediatric Subjects 2 to 8 Years of Age After the Fontan Procedure",No,719471221,2020,01/20/2023,,,
7685,UNCHANGED,Covered Recipient Teaching Hospital,,43300.0,9600.0,ARKANSAS CHILDRENS HOSPITAL,,,,,,,1 Childrens Way,,Little Rock,AR,72202,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,781239.0,1689620890.0,MICHAEL,L,SCHMITZ,,ONE CHILDREN'S WAY,SLOT 203,LITTLE ROCK,AR,72202-3510,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Anesthesiology,,,,,,AR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,B. Braun Medical Inc.,100000000316,B. Braun Medical Inc.,PA,United States,Yes,Covered,Drug,INJECTIBLE DRUGS,CEFAZOLIN SODIUM,0264-3105-11,,,,,,,,,,,,,,,,,,,,,,,,,,2706.6,01/02/2020,Cash or cash equivalent,,,,,,,No,No,SAFETY OF 1 G AND 2 G OF CEFAZOLIN IN PEDIATRIC SUBJECTS,No,750598451,2020,01/20/2023,NCT03231228,,
9077,UNCHANGED,Covered Recipient Teaching Hospital,,490063.0,9377.0,INOVA FAIRFAX HOSPITAL,,,,,,,3300 Gallows Rd,,Falls Church,VA,22042,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,979995.0,1659390755.0,JOHN,F,DEEKEN,,8081 INNOVATION PARK DR,8081 INNOVATION PARK DR,FAIRFAX,VA,22031-4867,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,,,,,,DC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Merck Sharp & Dohme Corporation,100000000053,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Drug,ONCOLOGY,LENVIMA,62856-712-30,,,,,,,,,,,,,,,,,,,,,,,,,,0.11,04/08/2020,In-kind items and services,,,,,,,No,No,"A Phase 3, randomized, placebo-controlled, double-blind clinical study of pembrolizumab MK3475 with or without lenvatinib E7080,MK-7902 to evaluate the safety and efficacy of pembrolizumab and lenvatinib as 1L intervention in a PD-L1 selected population of participants with recurrent or metastatic head and neck squamous cell carcinoma R,M HNSCC LEAP-010",No,740794505,2020,01/20/2023,,,Equipment or non-drug supplies provided to a clinical study site.
4113,UNCHANGED,Covered Recipient Teaching Hospital,,10033.0,9569.0,University Of Alabama Hospital,,,,,,,619 South 19th Street,,Birmingham,AL,35233,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,325623.0,1174552004.0,HUGH,T,MCELDERRY,,619 19TH STREET SOUTH,,BIRMINGHAM,AL,35233,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology,,,,,,AL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Medical Device Business Services, Inc.",100000005706,"Medical Device Business Services, Inc.",IN,United States,Yes,Covered,Device,Cardiology,Visitag,,,,,,,,,,,,,,,,,,,,,,,,,,,2028.0,02/10/2020,Cash or cash equivalent,,,,,,,No,No,Evaluation of VISITAG SURPOINT Module with External Processing Unit (EPU) when used with the THERMOCOOL SMARTTOUCH SF and THERMOCOOL SMARTTOUCH Catheters for pulmonary vein isolation (PVI),No,719512057,2020,01/20/2023,,,
2969,UNCHANGED,Covered Recipient Teaching Hospital,,110010.0,9427.0,Emory University Hospital,,,,,,,1364 Clifton Rd Ne,,Atlanta,GA,30322,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,76459.0,1699961417.0,RAVI,,RAJANI,,69 JESSE HILL JR DR SE,"GLENN MEMORIAL BUILDING, ROOM 302",ATLANTA,GA,30303,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Surgery,,,,,,GA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Penumbra, Inc.",100000010583,"Penumbra, Inc.",CA,United States,Yes,Covered,Device,Peripheral Intervention,Indigo,,,,,,,,,,,,,,,,,,,,,,,,,,,1300.0,03/19/2020,Cash or cash equivalent,,,,,,,No,No,EXTRACT-PE,No,752347931,2020,01/20/2023,,,
8576,UNCHANGED,Covered Recipient Physician,,,,,218956.0,1841225521.0,SERGIO,,SCHWARTZMAN,,535 E 70TH ST,,NEW YORK,NY,10021-4872,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology,,,,,,NY,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,AbbVie Inc.,100000000204,AbbVie Inc.,IL,United States,Yes,Covered,Biological,IMMUNOLOGY,HUMIRA,0074-0554-02,,,,,,,,,,,,,,,,,,,,,,,,,,69.07,02/18/2020,In-kind items and services,,,,,,,Yes,No,,No,721143269,2020,01/20/2023,,,
6335,UNCHANGED,Covered Recipient Teaching Hospital,,360180.0,9025.0,CLEVELAND CLINIC HOSPITAL,,,,,,,9500 Euclid Avenue,,Cleveland,OH,44195,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,310609.0,1851355085.0,Michael,,Machuzak,,9500 Euclid Ave,,Cleveland,OH,44195,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease,,,,,,OH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Pulmonx Corporation,100000010976,Pulmonx Corporation,CA,United States,Yes,Covered,Device,Pulmonology,Pulmonx Endobronchial Valve EBV,,,,,,,,,,,,,,,,,,,,,,,,,,,250.0,02/12/2020,Cash or cash equivalent,Overhead,,,,,,No,No,Lung Function Improvement after Bronchoscopic Lung Volume Reduction with Pulmonx Endobronchial Valves used in Treatment of Emphysema,No,719696409,2020,01/20/2023,,,
510,UNCHANGED,Covered Recipient Teaching Hospital,,160058.0,9253.0,UNIVERSITY OF IOWA HOSP & CLINICS,,,,,,,200 HAWKINS DR,,IOWA CITY,IA,52242,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,1197702.0,1285897736.0,VARUN,VIJAY KUMAR,MONGA,,200 HAWKINS DR,"DEPT OF INTERNAL MEDICINE, C-32 GH",IOWA CITY,IA,52242,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,,,,,,IA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Amgen Inc.,100000000203,Amgen Inc.,CA,United States,Yes,Covered,Biological,Oncology,IMLYGIC,55513-078-01,,,,,,,,,,,,,,,,,,,,,,,,,,1036.0,09/22/2020,In-kind items and services,,,,,,,No,No,Neoadjuvant Intralesional Injection of Talimogene Laherparepvec with Concurrent Preoperative Radiation in Patients with Locally Advanced Soft Tissue Sarcomas,No,731650927,2020,01/20/2023,,,
8492,UNCHANGED,Covered Recipient Teaching Hospital,,220162.0,8640.0,Dana-Farber Cancer Institute,,,,,,,450 Brookline Ave,,Boston,MA,02215,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,114497.0,1528024270.0,MONICA,,BERTAGNOLLI,,75 FRANCIS ST CARRIE HALL 116,,BOSTON,MA,02115,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Surgery,,,,,,MA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Exelixis Inc.,100000010545,Exelixis Inc.,CA,United States,Yes,Covered,Drug,Oncology,Cabozantinib,42388-023-26,,,,,,,,,,,,,,,,,,,,,,,,,,25.0,02/11/2020,Cash or cash equivalent,,,,,,,No,No,"Randomized, Double-blinded Phase III Study of Cabozantinib versus Placebo in Patients with Advanced Neuroendocrine Tumors after Progression on Everolimus CABINET)",No,736579093,2020,01/20/2023,,,
7484,UNCHANGED,Covered Recipient Teaching Hospital,,360180.0,9025.0,CLEVELAND CLINIC HOSPITAL,,,,,,,9500 Euclid Ave,,Cleveland,OH,44195,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,1251558.0,1215197892.0,LE,H,HUA,,888 W BONNEVILLE AVE,,LAS VEGAS,NV,89106-0100,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology,,,,,,AZ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,AbbVie Inc.,100000000204,AbbVie Inc.,IL,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,20740.0,02/19/2020,Cash or cash equivalent,,,,,,,No,No,M14-397,No,721135563,2020,01/20/2023,NCT03737812,,
6440,UNCHANGED,Covered Recipient Teaching Hospital,,230038.0,9159.0,Spectrum Health Hospitals,,,,,,,100 MICHIGAN ST NE,,GRAND RAPIDS,MI,49503,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,326784.0,1215928684.0,ANDRE,JOHN,GAURI,,2900 Bradford St Ne,,Grand Rapids,MI,49525,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology,,,,,,MI,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Medtronic Vascular, Inc.",100000010384,"Medtronic Vascular, Inc.",MN,United States,Yes,Covered,Device,Ablation,Arctic Front,,,,,,,,,,,,,,,,,,,,,,,,,,,200.0,08/17/2020,Cash or cash equivalent,,,,,,,No,No,STOP AF First,No,728057203,2020,01/20/2023,,,
8323,UNCHANGED,Covered Recipient Teaching Hospital,,393303.0,8873.0,THE CHILDRENS HOSPITAL OF PHILADELP,,,,,,,34TH   CIVIC CENTER BLVD,PARC BUSINESS SERVICES,PHILADELPHIA,PA,19104,United States,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Genentech, Inc.",100000005726,Hoffmann-La Roche Limited,,Canada,Yes,Non-Covered,Drug,None,Non-Covered Product,,,,,,,,,,,,,,,,,,,,,,,,,,,991.0,02/06/2020,Cash or cash equivalent,,,,,,,No,No,STUDY TO ASSESS SCALES FOR RRB IN ASD NON DRUG STUDY DIGITAL BIOMARKER,No,743017603,2020,01/20/2023,,,
7560,UNCHANGED,Covered Recipient Teaching Hospital,,110010.0,9427.0,Emory University Hospital,,,,,,,1364 Clifton Rd NE,,Atlanta,GA,30322,United States,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,HOLOGIC INC,100000231815,"Gen-Probe, Inc.",MA,United States,Yes,Covered,Device,Diagnostics,Aptima,,,,,,,,,,,,,,,,,,,,,,,,,,,4274.4,12/01/2020,Cash or cash equivalent,,,,,,,No,No,P10934-CMVPS-CSP-01,No,714602439,2020,01/20/2023,,,Aptima CMV Quant Assay on the Panther R System
4966,UNCHANGED,Covered Recipient Teaching Hospital,,360163.0,8981.0,The Christ Hospital,,,,,,,2139 AUBURN AVE,,CINCINNATI,OH,45219,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,64866.0,1427025055.0,DEAN,,KEREIAKES,,2123 AUBURN AVE,,CINCINNATI,OH,45219-2906,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Interventional Cardiology,,,,,,OH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BOSTON SCIENTIFIC CORPORATION,100000005674,BOSTON SCIENTIFIC CORPORATION,MA,United States,Yes,Covered,Device,CLINICAL TRIAL PRODUCT,CLINICAL TRIAL PRODUCT,,,,,,,,,,,,,,,,,,,,,,,,,,,9762.0,05/18/2020,Cash or cash equivalent,,,,,,,No,No,REPRISE III,No,730134691,2020,01/20/2023,NCT02202434,,
1081,UNCHANGED,Covered Recipient Teaching Hospital,,440039.0,9077.0,Vanderbilt University Medical Center,,,,,,,1211 Medical Center Drive,,Nashville,TN,37232,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,4683914.0,1992148696.0,NATALIE,,MCCALL,,3601 THE VANDERBILT CLINIC,,NASHVILLE,TN,37232,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology,,,,,,TN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Novo Nordisk Inc,100000000163,Novo Nordisk AS,,Denmark,Yes,Covered,Drug,Diabetes,Ozempic,0169-4132-12,,,,,,,,,,,,,,,,,,,,,,,,,,3.25,08/19/2020,In-kind items and services,,,,,,,No,No,NN9535-4321,No,742365693,2020,01/20/2023,,,
9864,UNCHANGED,Covered Recipient Teaching Hospital,,440039.0,9077.0,Vanderbilt University Medical Center,,,,,,,1211 Medical Center Drive,,Nashville,TN,37232,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,409450.0,1629160056.0,MICHAEL,E,MAY,,1215 21ST AVE S,STE 8210,NASHVILLE,TN,37232,United States,,,Medical Doctor,,,,,,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",,,,,,TN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Novo Nordisk Inc,100000000163,Novo Nordisk AS,,Denmark,Yes,Covered,Drug,Diabetes,Ozempic,0169-4132-12,,,,,,,,,,,,,,,,,,,,,,,,,,1963.12,12/22/2020,Cash or cash equivalent,,,,,,,No,No,NN9535-4352,No,742365969,2020,01/20/2023,,,
3631,UNCHANGED,Covered Recipient Physician,,,,,127894.0,1811967433.0,MATTHEW,J,BUDOFF,,21840 NORMANDIE AVE,,TORRANCE,CA,90502,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease,,,,,,CA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Pfizer Inc.,100000000286,PFIZER INC.,NY,United States,Yes,Covered,Drug,CARDIOVASCULAR,STEGLATRO,0006-5363-03,,,,,,,,,,,,,,,,,,,,,,,,,,3200.0,12/21/2020,In-kind items and services,,,,,,,No,No,ERTUGLIFLOZIN CLINICAL PUBLICATION PROGRAM,No,742856261,2020,01/20/2023,,,No payment was made directly to this author. This is a fair market value payment for editorial or medical writing services paid to a 3rd-party vendor to assist with the development of a publication.
9712,UNCHANGED,Covered Recipient Teaching Hospital,,50262.0,9958.0,Ronald Reagan Ucla,,,,,,,757 Westwood Plaza,,Los Angeles,CA,90095,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,341256.0,1528093713.0,SVEN,,DEVOS,,650 Charles E Young Dr S,12-256 Factor Bldg,Los Angeles,CA,90095,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology,,,,,,CA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Pharmacyclics LLC, An AbbVie Company",100000136439,"Pharmacyclics LLC, An AbbVie Company",CA,United States,Yes,Covered,Drug,Oncology,Imbruvica,,,,,,,,,,,,,,,,,,,,,,,,,,,1939.14,11/03/2020,Cash or cash equivalent,,,,,,,No,No,PCYC-1143-CA,No,727737663,2020,01/20/2023,NCT03112174,,Phase 3 Study of Ibrutinib in Combination with Venetoclax in Subjects with Mantle Cell Lymphoma
4722,UNCHANGED,Covered Recipient Teaching Hospital,,50599.0,9919.0,Uc Davis Medical Center,,,,,,,2315 Stockton Blvd,,Sacramento,CA,95817,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,694341.0,1619263514.0,MAY,T,CHO,,No Address Provided,,SAINT LOUIS,MO,63110,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine,,,,,,CA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"BeiGene, Ltd.",100000826833,"BeiGene, Ltd.",,Cayman Islands,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1321.0,08/13/2020,Cash or cash equivalent,,,,,,,No,No,"A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Clinical Study Comparing the Efficacy and Safety of Tislelizumab (BGB-A317) Plus Platinum and Fluoropyrimidine Versus Placebo Plus Platinum and Fluoropyrimidine as First-Line Treatment in Patients Wi",No,753002319,2020,01/20/2023,NCT03777657,,
7976,UNCHANGED,Covered Recipient Teaching Hospital,,380009.0,9844.0,Ohsu Hospital And Clinics,,,,,,,3181 Sw Sam Jackson Park Rd,,Portland,OR,97239,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,98429.0,1174770382.0,HORMOZD,,BOZORGCHAMI,,3181 SW SAM JACKSON PARK RD,MAILCODE CDRC-P,PORTLAND,OR,97239,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology,,,,,,CA,OR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Novo Nordisk Inc,100000000163,Novo Nordisk AS,,Denmark,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,16.25,06/10/2020,In-kind items and services,,,,,,,No,No,EX9536-4388,No,742449515,2020,01/20/2023,,,
4267,UNCHANGED,Covered Recipient Teaching Hospital,,30014.0,9791.0,John C Lincoln Medical Center,,,,,,,250 West Dunlap,,Phoenix,AZ,85020,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,277405.0,1114929114.0,MICHAEL,S,GORDON,,9055 E DEL CAMINO DR,SUITE 100,SCOTTSDALE,AZ,85258-2351,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,,,,,,AZ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Daiichi Sankyo Inc.,100000000195,Daiichi Sankyo Inc.,NJ,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1434.5,07/09/2020,Cash or cash equivalent,,,,,,,No,No,PL3397-A-U126,No,745478475,2020,01/20/2023,NCT03291288,,
3718,UNCHANGED,Covered Recipient Teaching Hospital,,50262.0,9958.0,RONALD REAGAN UCLA,,,,,,,757 Westwood Plz,,Los Angeles,CA,90095,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,173135.0,1821076639.0,SUPHAMAI,,BUNNAPRADIST,,200 UCLA MEDICAL PLZ STE 565C,200 UCLA MEDICAL PLZ STE 565C,LOS ANGELES,CA,90095-1865,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology,,,,,,CA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Merck Sharp & Dohme Corporation,100000000053,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Drug,INFECTIOUS DISEASE,PREVYMIS,0006-5004-01,,,,,,,,,,,,,,,,,,,,,,,,,,47.0,06/08/2020,In-kind items and services,,,,,,,No,No,"A Phase III, Randomized, Double-Blind, Comparator-controlled Study to Evaluate the Efficacy and Safety of MK-8228 Letermovir Versus Valganciclovir for the Prevention of Human Cytomegalovirus CMV Disease in Adult Kidney Transplant Recipients",No,740757619,2020,01/20/2023,,,Equipment or non-drug supplies provided to a clinical study site.
3076,UNCHANGED,Covered Recipient Teaching Hospital,,230077.0,9151.0,ST. MARYS OF MICHIGAN,,,,,,,800 S Washington Ave,,Saginaw,MI,48601,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,110236.0,1427089200.0,VIPIN,,KHETARPAL,,1015 S WASHINGTON AVE,,SAGINAW,MI,48601-2556,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease,,,,,,MI,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Esperion Therapeutics, Inc.",100000771817,"Esperion Therapeutics, Inc.",MI,United States,Yes,Covered,Drug,ANTILIPEMIC AGENTS,NEXLETOL,72426-118-03,,,,,,,,,,,,,,,,,,,,,,,,,,100.0,11/19/2020,Cash or cash equivalent,,,,,,,No,No,"A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENCE OF MAJOR CARDIOVASCULAR EVENTS IN PATIENTS WITH, OR AT HIGH RISK FOR, CARDIOVASCULAR DISEASE WHO ARE STATIN INTOLERANT",No,737190129,2020,01/20/2023,,,
6495,UNCHANGED,Covered Recipient Teaching Hospital,,460009.0,9799.0,U OF U HOSPITALS & CLINICS,,,,,,,50 N Medical Dr,,Salt Lake City,UT,84132,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,7414652.0,1457779035.0,KATHLEEN,CLAIRE,KERRIGAN,,410 W 10TH AVE,410 W 10TH AVE,COLUMBUS,OH,43210-1240,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,,,,,,OH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Merck Sharp & Dohme Corporation,100000000053,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Drug,ONCOLOGY,LENVIMA,62856-712-30,,,,,,,,,,,,,,,,,,,,,,,,,,47.25,08/10/2020,In-kind items and services,,,,,,,No,No,"A Phase 2, randomized, open-label three-arm clinical study to evaluate the safety and efficacy of lenvatinib E7080,MK-7902 in combination with pembrolizumab MK-3475 versus standard of care chemotherapy and lenvatinib monotherapy in participants with recurrent,metastatic head and neck squamous cell carcinoma R,M HNSCC that have progressed after platinum therapy and immunotherapy PD-1,PD-L1 inhibitors LEAP-009",No,740759415,2020,01/20/2023,,,Equipment or non-drug supplies provided to a clinical study site.
2374,UNCHANGED,Covered Recipient Teaching Hospital,,370114.0,9628.0,St. John Medical Center,,,,,,,1923 S Utica Ave,,Tulsa,OK,74104,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,512253.0,1225284094.0,NICHOLAS,NABIL,HANNA,,1923 S UTICA AVE,,TULSA,OK,74104,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine,,,,,,OK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Cardiovascular Systems Inc.,100000000117,Cardiovascular Systems Inc.,MN,United States,Yes,Covered,Device,Atherectomy Device,Coronary Orbital Atherectomy System,,,,,,,,,,,,,,,,,,,,,,,,,,,260.7,03/12/2020,Cash or cash equivalent,Patient Care,,,,,,No,No,ECLIPSE,No,752412429,2020,01/20/2023,NCT03108456,,Prospective randomized one to one (1:1) multi-center trial designed to evaluate vessel preparation with Orbital Atherectomy (OA) compared to conventional balloon angioplasty technique prior to stent implantation for the treatment of severely calcified coronary artery lesions.
730,UNCHANGED,Covered Recipient Teaching Hospital,,50760.0,9853.0,KFH - ANTIOCH,,,,,,,4501 SAND CREEK ROAD,,ANTIOCH,CA,94531,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,1081946.0,1245318815.0,NICOLA,P,KLEIN,,1 KAISER PLZ FL 16,KAISER PERMANENTE VACCINE STUDY CENTER,OAKLAND,CA,94612,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Pediatrics,,,,,,CA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Pfizer Inc.,100000000286,PFIZER INC.,NY,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,28343.25,12/29/2020,Cash or cash equivalent,,,,,,,No,No,A PHASE 123 PLACEBOCONTROLLED RANDOMIZED OBSERVERBLIND DOSEFINDING STUDY TO EVALUATE THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF SARSCOV2 RNA VACCINE CANDIDATES AGAINST COVID19 IN HEALTHY ADULTS,No,742899849,2020,01/20/2023,,,
8962,UNCHANGED,Covered Recipient Teaching Hospital,,50599.0,9919.0,UC DAVIS MEDICAL CENTER,,,,,,,2315 Stockton Blvd,,Sacramento,CA,95817,United States,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,CANON MEDICAL RESEARCH  USA INC.,100000010563,CANON MEDICAL RESEARCH  USA INC.,IL,United States,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,50000.0,06/18/2020,Cash or cash equivalent,,,,,,,Yes,No,,No,732772267,2020,01/20/2023,,,
8734,UNCHANGED,Covered Recipient Teaching Hospital,,490009.0,9389.0,University Of Virginia Medical Cente,,,,,,,1215 LEE ST PFS,,CHARLOTTESVILLE,VA,22908,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,601536.0,1376609610.0,MICHAEL,,RAGOSTA,,1215 LEE ST,,CHARLOTTESVILLE,VA,22908,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease,,,,,,VA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BIOTRONIK INC.,100000010579,BIOTRONIK INC.,OR,United States,Yes,Covered,Device,Cardiology/Vascular Diseases,Orsiro,,,,,,,,,,,,,,,,,,,,,,,,,,,78.0,07/14/2020,Cash or cash equivalent,,,,,,,No,No,BIOFLOW-VII,No,751888563,2020,01/20/2023,,,
3461,UNCHANGED,Covered Recipient Physician,,,,,1116450.0,1447291992.0,JOHN,,DAY,,300 PASTEUR DR,,STANFORD,CA,94305,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology,,,,,,CA,MN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Genentech, Inc.",100000005656,F. Hoffmann-La Roche AG,,Switzerland,Yes,Non-Covered,Drug,None,Non-Covered Product,,,,,,,,,,,,,,,,,,,,,,,,,,,309.1,06/30/2020,In-kind items and services,,,,,,,No,No,"AN OPEN-LABEL STUDY TO INVESTIGATE THE SAFETY, TOLERABILITY, AND PHARMACOKINETICSPHARMACODYNAMICS OF RO7034067 IN ADULT AND PEDIATRIC PATIENTS WITH SPINAL MUSCULAR ATROPHY",No,742983539,2020,01/20/2023,,,
3816,UNCHANGED,Covered Recipient Teaching Hospital,,110010.0,9427.0,EMORY UNIVERSITY HOSPITAL,,,,,,,1364 Clifton Rd Ne,,Atlanta,GA,30322,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,657046.0,1285877209.0,DANENG,,LI,,1500 DUARTE RD,1500 DUARTE RD,DUARTE,CA,91010-3012,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,,,,,,CA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Merck Sharp & Dohme Corporation,100000000053,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Biological,ONCOLOGY,KEYTRUDA,0006-3029-02,,,,,,,,,,,,,,,,,,,,,,,,,,298.98,02/26/2020,In-kind items and services,,,,,,,No,No,A Phase 2 Study of Pembrolizumab MK-3475 as Monotherapy in Subjects with Advanced Hepatocellular Carcinoma KEYNOTE-224,No,740825561,2020,01/20/2023,,,Equipment or non-drug supplies provided to a clinical study site.
5604,UNCHANGED,Covered Recipient Physician,,,,,823760.0,1174787352.0,FUAD,,EL RASSI,,49 JESSE HILL JR DR SE,,ATLANTA,GA,30303-3049,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,,,,,,GA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Novartis Pharmaceuticals Corporation,100000000228,Novartis Pharmaceuticals Corporation,NJ,United States,Yes,Covered,Biological,HEMATOLOGY,ADAKVEO,0078-0883-61,,,,,,,,,,,,,,,,,,,,,,,,,,178.0,02/28/2020,In-kind items and services,,,,,,,No,No,RESEARCH RELATED PUBLICATIONS SUPPORT,No,721486561,2020,01/20/2023,,,
5259,UNCHANGED,Covered Recipient Teaching Hospital,,500014.0,9076.0,PROV REGL MED CENTER EVERETT,,,,,,,1321 Colby Ave,,Everett,WA,98201,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,52391.0,1164523130.0,GEORGE,A,DIAZ,,1330 ROCKEFELLER AVE,SUITE 210,EVERETT,WA,98201-1684,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease,,,,,,WA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Regeneron Pharmaceuticals, Inc.",100000000069,"Regeneron Pharmaceuticals, Inc.",NY,United States,Yes,Covered,Biological,INFLAMMATION AND  IMMUNOLOGY,KEVZARA,0024-5908-01,,,,,,,,,,,,,,,,,,,,,,,,,,12287.99,08/27/2020,Cash or cash equivalent,,,,,,,No,No,"An Adaptive Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study Assessing Efficacy and Safety of Sarilumab for Hospitalized Patients With COVID-19",No,724445849,2020,01/20/2023,NCT04315298,,
8446,UNCHANGED,Covered Recipient Teaching Hospital,,10033.0,9569.0,University Of Alabama Hospital,,,,,,,619 19th St S,,Birmingham,AL,35249,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,936030.0,1114947769.0,WILLIAM,T,GARVEY,,3824 ROCK CREEK TRL,,MOUNTAIN BRK,AL,35223,United States,,,Medical Doctor,,,,,,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",,,,,,AL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Novo Nordisk Inc,100000000163,Novo Nordisk AS,,Denmark,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,85.35,02/18/2020,In-kind items and services,,,,,,,No,No,NN9536-4576,No,742362163,2020,01/20/2023,,,
8118,UNCHANGED,Covered Recipient Physician,,,,,68002.0,1508908328.0,SARANYA,,CHUMSRI,,4500 SAN PABLO RD S,,JACKSONVILLE,FL,32224-1865,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,,,,,,FL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Bausch Health Americas, Inc.",100000010935,"Bausch Health US, LLC",NJ,United States,Yes,Covered,Drug,GASTROENTEROLOGY,XIFAXAN,65649-303-02,,,,,,,,,,,,,,,,,,,,,,,,,,7666.77,05/20/2020,Cash or cash equivalent,,,,,,,No,No,2017-3062 Chumsri,No,737372185,2020,01/20/2023,,,
8675,UNCHANGED,Covered Recipient Physician,,,,,303222.0,1679551444.0,BRADLEY,S,GIEDD,,1928 HOWELL BRANCH RD,,WINTER PARK,FL,32792-1013,United States,,,Doctor of Optometry,,,,,,Eye and Vision Services Providers|Optometrist,,,,,,FL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Alcon Research LLC,100000000218,Alcon Research LLC,TX,United States,Yes,Covered,Device,Ophthalmology,Precision 1,,,,,,,,,,,,,,,,,,,,,,,,,,,450.0,02/12/2020,Cash or cash equivalent,,,,,,,No,No,Clinical Performance of a Toric Silicone Hydrogel Daily Disposable Lens,No,733468379,2020,01/20/2023,,,
8330,UNCHANGED,Covered Recipient Physician,,,,,53652.0,1194800052.0,TIMOTHY,S.,BAILEY,,625 Citracado Pkwy Ste 108,,Escondido,CA,92025,United States,,,Medical Doctor,,,,,,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",,,,,,CA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Sanofi and Genzyme US Companies,100000000076,SANOFI-AVENTIS U.S. LLC,NJ,United States,Yes,Covered,Biological,Endocrinology,TOUJEO,0024-5869-03,,,,,,,,,,,,,,,,,,,,,,,,,,544.97,03/31/2020,In-kind items and services,,,,,,,No,No,"A randomized, open-label, parallel group real world pragmatic trial to assess the clinical and health outcomes of Toujeo compared to commercially available basal insulins for initiation of therapy in",No,744033899,2020,01/20/2023,,,
4098,UNCHANGED,Covered Recipient Physician,,,,,5340180.0,1710466248.0,Sue,,Kim,,1308 ORCHARD AVE,0,LOS ANGELES,CA,90006,United States,,,Doctor of Dentistry,,,,,,Dental Providers|Dentist|Orthodontics and Dentofacial Orthopedics,,,,,,CA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Align Technology, Inc.",100000005613,"Align Technology, Inc.",CA,United States,Yes,Covered,Device,Orthodontics,Invisalign,,,,,,,,,,,,,,,,,,,,,,,,,,,20.0,11/21/2020,Cash or cash equivalent,Other,,,,,,No,No,Online Research Survey,No,752859189,2020,01/20/2023,,,
9635,UNCHANGED,Covered Recipient Teaching Hospital,,340091.0,9436.0,THE MOSES H. CONE MEMORIAL HOSPITAL,,,,,,,1200 N Elm St,,Greensboro,NC,27401,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,61319.0,1346293784.0,MOHAMED,KAMEL,MOHAMED,,501 N ELAM AVE,501 N ELAM AVE,GREENSBORO,NC,27403-1118,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology,,,,,,NC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Merck Sharp & Dohme Corporation,100000000053,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Drug,ONCOLOGY,LENVIMA,62856-712-30,,,,,,,,,,,,,,,,,,,,,,,,,,27.85,05/11/2020,In-kind items and services,,,,,,,No,No,"A Phase 3, randomized, double blind trial of pembrolizumab MK 3475 with or without lenvatinib in participants with treatment-na ve, metastatic non-small cell lung cancer NSCLC who have a tumor proportion score TPS greater than or equal to 1",No,740748145,2020,01/20/2023,,,Equipment or non-drug supplies provided to a clinical study site.
2580,UNCHANGED,Covered Recipient Teaching Hospital,,230297.0,8803.0,KARMANOS CANCER HOSPITAL,,,,,,,4100 John R St,,Detroit,MI,48201,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,157764.0,1467611475.0,STEVEN,D,DAVELUY,,18100 OAKWOOD BLVD,SUITE 300,DEARBORN,MI,48124-4085,United States,,,Doctor of Osteopathy,,,,,,Allopathic & Osteopathic Physicians|Dermatology,,,,,,MI,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Regeneron Pharmaceuticals, Inc.",100000000069,"Regeneron Pharmaceuticals, Inc.",NY,United States,Yes,Covered,Biological,ONCOLOGY,LIBTAYO,61755-008-01,,,,,,,,,,,,,,,,,,,,,,,,,,300.0,12/15/2020,Cash or cash equivalent,,,,,,,No,No,"A PHASE 2 STUDY OF REGN2810, A FULLY HUMAN MONOCLONAL ANTIBODY TO PROGRAMMED DEATH-1 (PD-1), IN PATIENTS WITH ADVANCED CUTANEOUS SQUAMOUS CELL CARCINOMA",No,724443601,2020,01/20/2023,NCT02760498,,
208,UNCHANGED,Covered Recipient Teaching Hospital,,50146.0,9927.0,CITY OF HOPE NATIONAL MEDICAL CTR,,,,,,,1500 E Duarte Rd,,Duarte,CA,91010,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,99785.0,1184987166.0,YAN,,XING,,1500 E DUARTE ROAD,1500 E DUARTE ROAD,DUARTE,CA,91010,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,,,,,,CA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Merck Sharp & Dohme Corporation,100000000053,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Drug,ONCOLOGY,LENVIMA,62856-712-30,,,,,,,,,,,,,,,,,,,,,,,,,,62.25,08/10/2020,In-kind items and services,,,,,,,No,No,"A Phase 2, randomized, open-label three-arm clinical study to evaluate the safety and efficacy of lenvatinib E7080,MK-7902 in combination with pembrolizumab MK-3475 versus standard of care chemotherapy and lenvatinib monotherapy in participants with recurrent,metastatic head and neck squamous cell carcinoma R,M HNSCC that have progressed after platinum therapy and immunotherapy PD-1,PD-L1 inhibitors LEAP-009",No,740713923,2020,01/20/2023,,,Equipment or non-drug supplies provided to a clinical study site.
5968,UNCHANGED,Covered Recipient Teaching Hospital,,110010.0,9427.0,EMORY UNIVERSITY HOSPITAL,,,,,,,1364 Clifton Rd Ne,,Atlanta,GA,30322,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,754913.0,1750312252.0,JENNIFER,,CHRISTIE,,1365 CLIFTON RD NE,,ATLANTA,GA,30322-1013,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology,,,,,,GA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Allergan, Inc.",100000000278,"Allergan, Inc.",NJ,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,416.0,04/01/2020,Cash or cash equivalent,,,,,,,No,No,"46 weeks, placebo controlled (pts from 01/02 studies roll over for 53 weeks total exposure)",No,721242539,2020,01/20/2023,,,
3339,UNCHANGED,Covered Recipient Physician,,,,,286917.0,1316957350.0,SATISH,S,MODI,,23 DAVIS AVENUE,,POUGHKEEPSIE,NY,12603,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Ophthalmology,,,,,,NY,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Alcon Research LLC,100000000218,Alcon Research LLC,TX,United States,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,919.4,02/05/2020,Cash or cash equivalent,,,,,,,No,No,Mercury Extended Wear Registration Trial(Weekly SiHy NW Sphere (Mercury)),No,733469359,2020,01/20/2023,,,
7146,UNCHANGED,Covered Recipient Physician,,,,,342220.0,1538147061.0,JAMES,D,BRANCH,,224 TOWN RUN LN,,WINSTON-SALEM,NC,27101-3911,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Ophthalmology,,,,,,NC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Allergan, Inc.",100000000278,"Allergan, Inc.",NJ,United States,Yes,Covered,Drug,OPHTHALMOLOGY,LUMIGAN,0023-3205-08,,,,,,,,,,,,,,,,,,,,,,,,,,7860.3,11/20/2020,Cash or cash equivalent,,,,,,,No,No,An Extension Trial to Evaluate the Long-term Safety and Efficacy of Bimatoprost SR in Patients with Open Angle Glaucoma or Ocular Hypertension,No,721244091,2020,01/20/2023,,,
9275,UNCHANGED,Covered Recipient Teaching Hospital,,360068.0,9048.0,The Toledo Hospital,,,,,,,2142 N COVE BLVD,,TOLEDO,OH,43606,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,70978.0,1568487726.0,MARK,,RICHARDS,,2940 N MCCORD RD,,TOLEDO,OH,43615,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Clinical Cardiac Electrophysiology,,,,,,MI,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BIOTRONIK INC.,100000010579,BIOTRONIK INC.,OR,United States,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,20.0,09/09/2020,Cash or cash equivalent,,,,,,,No,No,BIO-LIBRA,No,751909973,2020,01/20/2023,,,
5359,UNCHANGED,Covered Recipient Teaching Hospital,,50625.0,9924.0,Cedars-Sinai Medical Center,,,,,,,8700 BEVERLY BLVD,,LOS ANGELES,CA,90048,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,189090.0,1164450235.0,RAJENDRA,R.,MAKKAR,,127 S San Vicente Blvd,,Los Angeles,CA,90048,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Interventional Cardiology,,,,,,CA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Edwards Lifesciences Corporation,100000010633,Edwards Lifesciences Corporation,CA,United States,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,48816.59,07/02/2020,Cash or cash equivalent,,,,,,,No,No,Early-TAVR Trial #2016-07,No,736544427,2020,01/20/2023,,,
5396,UNCHANGED,Covered Recipient Teaching Hospital,,390111.0,8882.0,HOSPITAL OF THE UNIV OF PENNA,,,,,,,3400 Spruce St,,Philadelphia,PA,19104,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,273837.0,1043247935.0,EMILY,A,BLUMBERG,,3400 SPRUCE STREET,3 SILVERSTEIN SUITE D,PHILADELPHIA,PA,19104-4206,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease,,,,,,PA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Takeda Pharmaceuticals U.S.A., Inc.",100000000337,"Takeda Pharmaceuticals U.S.A., Inc.",IL,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1585.57,08/04/2020,Cash or cash equivalent,,,,,,,No,No,"A PHASE 3, MULTICENTER, RANDOMIZED, OPEN-LABEL, ACTIVE-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF SHP620 COMPARED TO STANDARD OF CARE FOR THE TREATMENT OF CYTOMEGALOVIRUS (CMV) INFECTIONS THAT ARE RESISTANT OR REFRACTORY TO TREATMENT WITH GANCICLOVIR, VALGANCICLOVIR, FOSCARNET, OR CIDOFOVIR IN TRANSPLANT RECIPIENTS",No,737062367,2020,01/20/2023,,,
3813,UNCHANGED,Covered Recipient Teaching Hospital,,110010.0,9427.0,EMORY UNIVERSITY HOSPITAL,,,,,,,1364 Clifton Rd Ne,,Atlanta,GA,30322,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,114281.0,1528175205.0,DAVID,H,LAWSON,,1365 CLIFTON RD NE,1365 CLIFTON RD NE,ATLANTA,GA,30322-1013,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,,,,,,GA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Merck Sharp & Dohme Corporation,100000000053,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Biological,ONCOLOGY,KEYTRUDA,0006-3029-02,,,,,,,,,,,,,,,,,,,,,,,,,,2500.0,04/03/2020,Cash or cash equivalent,,,,,,,No,No,"Randomized, Phase II Study of MK-3475 versus Chemotherapy in Patients with Advanced Melanoma",No,740825305,2020,01/20/2023,,,
9681,UNCHANGED,Covered Recipient Teaching Hospital,,100025.0,9454.0,Sacred Heart Hospital,,,,,,,5151 N 9th Ave,,Pensacola,FL,32504,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,16879.0,1356474548.0,DANY,,EL-SAYAH,,1545 Airport Blvd,Ste 2000,Pensacola,FL,32504,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,,,,,,FL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Pharmacyclics LLC, An AbbVie Company",100000136439,"Pharmacyclics LLC, An AbbVie Company",CA,United States,Yes,Covered,Drug,Oncology,Imbruvica,,,,,,,,,,,,,,,,,,,,,,,,,,,200.0,09/17/2020,Cash or cash equivalent,,,,,,,No,No,PCYC-1134M-CA,No,727734460,2020,01/20/2023,NCT02582879,,informCLL A Disease Registry for Patients with Chronic Lymphocytic Leukemia
5691,UNCHANGED,Covered Recipient Teaching Hospital,,100258.0,9699.0,Delray Medical Center,,,,,,,5352 Linton Blvd,,Delray Beach,FL,33484,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,199184.0,1407824097.0,JOSEPH,,RICOTTA,,"4205 W Atlantic Ave Bldg B, Ste 201",,Delray Beach,FL,33445,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Surgery|Vascular Surgery,,,,,,FL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BOSTON SCIENTIFIC CORPORATION,100000005674,Boston Scientific Corporation,MA,United States,Yes,Covered,Device,PERIPHERAL VASCULAR,EKOSONIC,,,,,,,,,,,,,,,,,,,,,,,,,,,227.5,09/11/2020,Cash or cash equivalent,,,,,,,No,No,KNOCOUT PE,No,734743065,2020,01/20/2023,NCT03426124,,
6435,UNCHANGED,Covered Recipient Teaching Hospital,,390196.0,8870.0,American Oncologic Hospial,,,,,,,333 Cottman Ave,,Philadelphia,PA,19111,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,579955.0,1619139235.0,Jessica,R,Bauman,,333 Cottman Ave,,Philadelphia,PA,19111-2434,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,,,,,,PA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Innate Pharma, Inc",100000791824,"Innate Pharma, Inc",MD,United States,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2600.0,06/01/2020,Cash or cash equivalent,,,,,,,No,No,Study of IPH2201 (Monalizumab) and Cetuximab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck,No,714615837,2020,01/20/2023,,,
3566,UNCHANGED,Covered Recipient Teaching Hospital,,310001.0,8837.0,HACKENSACK UNIVERSITY MEDICAL CENTER,,,,,,,30 Prospect Ave,,Hackensack,NJ,07601,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,240769.0,1306805460.0,ROBERT,S,ALTER,,92 2ND ST,92 2ND ST,HACKENSACK,NJ,07601-2191,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,,,,,,NJ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Merck Sharp & Dohme Corporation,100000000053,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Drug,ONCOLOGY,LENVIMA,62856-712-30,,,,,,,,,,,,,,,,,,,,,,,,,,0.55,08/10/2020,In-kind items and services,,,,,,,No,No,"A Phase 2, randomized, open-label three-arm clinical study to evaluate the safety and efficacy of lenvatinib E7080,MK-7902 in combination with pembrolizumab MK-3475 versus standard of care chemotherapy and lenvatinib monotherapy in participants with recurrent,metastatic head and neck squamous cell carcinoma R,M HNSCC that have progressed after platinum therapy and immunotherapy PD-1,PD-L1 inhibitors LEAP-009",No,740785017,2020,01/20/2023,,,Equipment or non-drug supplies provided to a clinical study site.
5071,UNCHANGED,Covered Recipient Teaching Hospital,,160058.0,9253.0,University Of Iowa Hosp & Clinics,,,,,,,200 HAWKINS DR,,IOWA CITY,IA,52242,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,613414.0,1790772846.0,PETAR,S.,LENERT,,200 Hawkins Dr,,Iowa City,IA,52242,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine,,,,,,IA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Sanofi and Genzyme US Companies,100000000067,SANOFI US SERVICES INC.,NJ,United States,Yes,Covered,Biological,Immunology,KEVZARA,0024-5908-01,,,,,,,,,,,,,,,,,,,,,,,,,,6750.26,05/18/2020,Cash or cash equivalent,,,,,,,No,No,"A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Sarilumab in Patients With Polymyalgia Rheumatica",No,744083689,2020,01/20/2023,NCT03600818,,
7543,UNCHANGED,Covered Recipient Teaching Hospital,,380009.0,9844.0,Ohsu Hospital And Clinics,,,,,,,3181 SW SAM JACKSON PARK RD,,PORTLAND,OR,97239,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,99883.0,1215005558.0,ALAN,F,BARKER,,3181 SW SAM JACKSON PARK RD,STE 320,PORTLAND,OR,97239,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease,,,,,,OR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Grifols Shared Services North America, Inc.",100000005422,Grifols Therapeutics LLC,CA,United States,Yes,Covered,Biological,Pulmonology,Prolastin-C,13533-701-01,,,,,,,,,,,,,,,,,,,,,,,,,,1450.8,01/24/2020,Cash or cash equivalent,,,,,,,No,No,"A Randomized, Double-Blind, Placebo Controlled Study to Assess the Efficacy and Safety of Two Dose Regimens 60 mgkg and 120 mgkg of Weekly Intravenous Alpha1 Proteinase Inhibitor Human in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin D",No,750461721,2020,01/20/2023,NCT01983241,,
3141,UNCHANGED,Covered Recipient Teaching Hospital,,53303.0,9933.0,Rady Childrens Hospital - San Diego,,,,,,,3020 CHILDRENS WAY,MAIL CODE 5002,SAN DIEGO,CA,92123,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,712383.0,1245302561.0,WILLIAM,D.,ROBERTS,,3010 CHILDRENS WAY,# 2-WEST,SAN DIEGO,CA,92123,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Hematology-Oncology,,,,,,CA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Incyte Corporation,100000000263,Incyte Corporation,DE,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,12.36,03/09/2020,Cash or cash equivalent,,,,,,,No,No,"A Pilot Study of the Immunological Effects of Neo Adjuvant INCB024360 in Patients with Epithelial Ovarian, Fallopian Tube or Primary CITN-05 Peritoneal Carcinoma",No,744319503,2020,01/20/2023,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
1754,UNCHANGED,Covered Recipient Teaching Hospital,,140091.0,9145.0,CARLE FOUNDATION HOSPITAL,,,,,,,611 W Park St,,Urbana,IL,61801,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,232959.0,1124077714.0,MARIA,T,GROSSE PERDEKAMP,,509 W UNIVERSITY,,URBANA,IL,61801,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,,,,,,IL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Pfizer Inc.,100000000286,PFIZER INC.,NY,United States,Yes,Covered,Drug,ONCOLOGY,IBRANCE,0069-0187-21,,,,,,,,,,,,,,,,,,,,,,,,,,600.0,01/15/2020,Cash or cash equivalent,,,,,,,No,No,PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRINE THERAPY VERSUS STANDARD ADJUVANT ENDOCRINE THERAPY ALONE FOR HR OR HER2 EARLY BREAST CANCE,No,742891767,2020,01/20/2023,,,
9533,UNCHANGED,Covered Recipient Physician,,,,,833679.0,1528160199.0,ANDREW,J,ARMSTRONG,,4101 N ROXBORO ST,,DURHAM,NC,27704-2121,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,,,,,,NC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Astellas Pharma Global Development,100000005406,Astellas Pharma Global Development,IL,United States,Yes,Covered,Drug,ONCOLOGY,XTANDI,0469-0125-99,,,,,,,,,,,,,,,,,,,,,,,,,,172.28,05/31/2020,In-kind items and services,,,,,,,No,No,A Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC),No,721318935,2020,01/20/2023,NCT02677896,,
3971,UNCHANGED,Covered Recipient Physician,,,,,481071.0,1124298146.0,SEMIRAMIDA,F,CONDOIANIS,,1865 HILLVIEW ST,,SARASOTA,FL,34239-3606,United States,,,Doctor of Dentistry,,,,,,Dental Providers|Dentist,,,,,,CO,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Kerr Corporation,100000005552,Kerr Corporation,CA,United States,Yes,Covered,Device,RESTORATIVE DENTISTRY,OPTIBOND UNIVERSAL,,,,,,,,,,,,,,,,,,,,,,,,,,,156.25,11/30/2020,Cash or cash equivalent,,,,,,,No,No,OPTIBOND UNIVERSAL,No,750928681,2020,01/20/2023,,,
2983,UNCHANGED,Covered Recipient Teaching Hospital,,220086.0,8638.0,Beth Israel Deaconess Medical Center,,,,,,,330 Brookline Avenue,,Boston,MA,02215,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,1094926.0,1699984070.0,ROBERT,W,HALLOWELL,,55 FRUIT ST,,BOSTON,MA,02114-2696,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease,,,,,,MA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Boehringer Ingelheim USA, Inc.",100000005541,Boehringer Ingelheim International GmbH,,Germany,Yes,Covered,Drug,RESPIRATORY,OFEV,0597-0143-60,,,,,,,,,,,,,,,,,,,,,,,,,,57.4,05/01/2020,In-kind items and services,,,,,,,No,No,Nintedanib in PF-ILD (extension),No,749895963,2020,01/20/2023,,,
9313,UNCHANGED,Covered Recipient Teaching Hospital,,363303.0,9020.0,Childrens Hospital Medical Center,,,,,,,1 PERKINS SQ,,AKRON,OH,44308,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,5701797.0,1639411788.0,MATTHEW,RUSSELL,GINSBERG,,One Perkins Square,Attn: Maura Freaney,Akron,OH,44308,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology,,,,,,OH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Alexion Pharmaceuticals, Inc.",100000005462,"Alexion Pharmaceuticals, Inc.",MA,United States,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2527.5,06/11/2020,Cash or cash equivalent,,,,,,,No,No,ECU-MG-303,No,724595299,2020,01/20/2023,,,"An open-label, multicenter study to evaluate the efficacy, safety, pharmacokinetics, and pharmacodynamics of eculizumab in pediatric patients with refractory generalized myasthenia gravis"
4840,UNCHANGED,Covered Recipient Teaching Hospital,,400016.0,9592.0,Auxilio Mutuo Hospital,,,,,,,Ponce De Leon,191227,San Juan,PR,00919,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,728419.0,1811052707.0,FERNANDO,,CABANILLAS,,725 PONCE DE LEON,PARADA 37,SAN JUAN,PR,00918,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,,,,,,PR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Eisai Inc.,100000000136,Eisai Inc.,NJ,United States,Yes,Covered,Drug,Oncology,Ontak,62856-603-01,,,,,,,,,,,,,,,,,,,,,,,,,,847.36,04/07/2020,Cash or cash equivalent,,,,,,,No,No,A Clinical Study to Demonstrate Safety and Efficacy of E7777 (Denileukin Diftitox) in Persistent or Recurrent Cutaneous T-Cell Lymphoma,No,749121917,2020,01/20/2023,,,
3329,UNCHANGED,Covered Recipient Teaching Hospital,,50077.0,9931.0,Scripps Mercy Hospital,,,,,,,4077 5th Ave,,San Diego,CA,92103,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,959048.0,1922105964.0,ATHENA,,PHILIS-TSIMIKAS,,10140 CAMPUS POINT DR,STE 200,SAN DIEGO,CA,92121,United States,,,Medical Doctor,,,,,,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",,,,,,CA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Novo Nordisk Inc,100000000163,Novo Nordisk AS,,Denmark,Yes,Covered,Drug,Diabetes,Ozempic,0169-4132-12,,,,,,,,,,,,,,,,,,,,,,,,,,1936.35,04/23/2020,Cash or cash equivalent,,,,,,,No,No,NN9535-4352,No,742439377,2020,01/20/2023,,,
7552,UNCHANGED,Covered Recipient Teaching Hospital,,63301.0,9762.0,CHILDRENS HOSPITAL COLORADO,,,,,,,13123 E 16th Ave,B010,Aurora,CO,80045,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,435746.0,1548465008.0,CHRISTINE,M,CHAN,,13123 E 16TH AVE,,AURORA,CO,80045-7106,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Endocrinology,,,,,,CO,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"DEXCOM, INC.",100000010478,"Dexcom, Inc.",CA,United States,Yes,Covered,Device,ENDOCRINOLOGY,DEXCOM G6 CGM SYSTEM,,,,,,,,,,,,,,,,,,,,,,,,,,,224.76,02/07/2020,In-kind items and services,,,,,,,No,No,SENSOR AUGMENTED PUMP (SAP) THERAPY FOR INPATIENT CYSTIC FIBROSIS RELATED DIABETES MANAGEMENT (CFRD),No,752063117,2020,01/20/2023,,,
334,UNCHANGED,Covered Recipient Teaching Hospital,,450076.0,9670.0,Ut Md Anderson Cancer Center,,,,,,,1515 Holcombe Blvd,,Houston,TX,77030,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,1281902.0,1447654470.0,ELENI,,EFSTATHIOU,,1515 HOLCOMBE BLVD,,HOUSTON,TX,77030,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,,,,,,TX,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Janssen Research & Development, LLC",100000005592,"Janssen Research & Development, LLC",NJ,United States,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1607.0,05/25/2020,Cash or cash equivalent,,,,,,,No,No,A Phase 2 Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies,No,719482449,2020,01/20/2023,,,
7277,UNCHANGED,Covered Recipient Teaching Hospital,,450076.0,9670.0,Ut Md Anderson Cancer Center,,,,,,,1515 Holcombe Blvd,,Houston,TX,77030,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,727133.0,1760701445.0,AMISHI,Y,SHAH,,1515 HOLCOMBE BLVD,,HOUSTON,TX,77030-4009,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,,,,,,PA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Eisai Inc.,100000000136,Eisai Inc.,NJ,United States,Yes,Covered,Drug,Oncology,Lenvima,62856-710-30,,,,,,,,,,,,,,,,,,,,,,,,,,2773.0,09/29/2020,Cash or cash equivalent,,,,,,,No,No,"A Multicenter, Open-Label Phase 1b/2 Trial of Lenvatinib (E7080) Plus Pembrolizumab in Subjects With Selected Solid Tumors",No,749121419,2020,01/20/2023,,,
4983,UNCHANGED,Covered Recipient Teaching Hospital,,430077.0,9289.0,Rapid City Regional Hospital,,,,,,,408 Knollwood Dr,,Rapid City,SD,57701,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,681346.0,1164479630.0,RACHEL,C,EDELEN,,640 FLORMANN ST,,RAPID CITY,SD,57701,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Endocrinology,,,,,,SD,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Novo Nordisk Inc,100000000163,Novo Nordisk AS,,Denmark,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,5.69,03/13/2020,In-kind items and services,,,,,,,No,No,NN9536-4451,No,742387903,2020,01/20/2023,,,
9183,UNCHANGED,Covered Recipient Teaching Hospital,,490024.0,9372.0,CARILION MEDICAL CENTER,,,,,,,1906 Belleview Ave Se,,Roanoke,VA,24014,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,1136559.0,1154430916.0,JUAN,,OLAZAGASTI,,102 HIGHLAND AVE SE STE 305,,ROANOKE,VA,24013-2253,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Gastroenterology,,,,,,VA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Regeneron Pharmaceuticals, Inc.",100000000069,"Regeneron Pharmaceuticals, Inc.",NY,United States,Yes,Covered,Biological,INFLAMMATION AND  IMMUNOLOGY,DUPIXENT,0024-5914-01,,,,,,,,,,,,,,,,,,,,,,,,,,130.0,04/29/2020,Cash or cash equivalent,,,,,,,No,No,"A PHASE 3, RANDOMIZED, 3-PART STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF DUPILUMAB IN ADULT AND ADOLESCENT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS (EOE)",No,724438709,2020,01/20/2023,NCT03633617,,
5035,UNCHANGED,Covered Recipient Teaching Hospital,,380061.0,9837.0,Providence Portland Medical Center,,,,,,,4805 Ne Glisan,,Portland,OR,97213,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,12160.0,1275548794.0,RACHEL,ELIZABETH,SANBORN,,4805 NE GLISAN ST STE 6N40,SUITE 6N40,PORTLAND,OR,97213,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,,,,,,OR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Pfizer Inc.,100000231820,ARRAY BIOPHARMA INC,CO,United States,Yes,Covered,Drug,ONCOLOGY,BRAFTOVI,70255-025-01,,,,,,,,,,,,,,,,,,,,,,,,,,8572.2,10/23/2020,Cash or cash equivalent,,,,,,,No,No,A PHASE 2 OPENLABEL STUDY OF ENCORAFENIB  BINIMETINIB IN PATIENTS WITH BRAFV600EMUTANT NONSMALL CELL LUNG CANCER,No,742876755,2020,01/20/2023,,,
4450,UNCHANGED,Covered Recipient Teaching Hospital,,450044.0,9703.0,Ut Southwestern University Hosp,,,,,,,5323 HARRY HINES BLVD,,DALLAS,TX,75390,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,804218.0,1497714521.0,CRAIG,S,GLAZER,,5323 HARRY HINES BLVD,,DALLAS,TX,75390-7208,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease,,,,,,TX,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Boehringer Ingelheim Pharma GmbH & Co.KG,100000010823,Boehringer Ingelheim Pharma GmbH & Co.KG,,Germany,Yes,Covered,Drug,RESPIRATORY,OFEV,0597-0143-60,,,,,,,,,,,,,,,,,,,,,,,,,,286.28,11/19/2020,In-kind items and services,,,,,,,No,No,Extension,No,750755223,2020,01/20/2023,,,
5000,UNCHANGED,Covered Recipient Teaching Hospital,,390027.0,8900.0,TEMPLE UNIVERSITY HOSPITAL,,,,,,,3401 N Broad St,,Philadelphia,PA,19140,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,18428.0,1417933987.0,JOSEPH,M,SEWARDS,,3401 N BROAD ST,6TH FLOOR OUTPATIENT BUILDING,PHILADELPHIA,PA,19140-5103,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Orthopaedic Surgery,,,,,,PA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Aesculap Biologics, LLC",100000005660,"Aesculap Biologics, LLC",PA,United States,Yes,Covered,Device,CARTILAGE REPAIR AND REGENERATION,NOVOCART 3D,,,,,,,,,,,,,,,,,,,,,,,,,,,1669.5,10/02/2020,Cash or cash equivalent,,,,,,,No,No,NOVOCART 3D FOR THE TREATMENT OF ARTICULAR CARTILAGE OF THE KNEE (N3D),No,717920613,2020,01/20/2023,NCT01957722,,
5649,UNCHANGED,Covered Recipient Teaching Hospital,,150021.0,9054.0,Parkview Hospital,,,,,,,11109 Parkview Plaza Drive,,Fort Wayne,IN,46845,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,16619.0,1366434342.0,ROY,W,ROBERTSON,,11108 PARKVIEW CIRCLE DR,,FORT WAYNE,IN,46845-1730,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease,,,,,,IN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,American Regent,100000010540,American Regent,NY,United States,Yes,Covered,Drug,Anemia,INJECTAFER,0517-0650-01,,,,,,,,,,,,,,,,,,,,,,,,,,2200.0,10/15/2020,Cash or cash equivalent,,,,,,,No,No,Heart_FID,No,737107239,2020,01/20/2023,NCT03037931,,
5003,UNCHANGED,Covered Recipient Teaching Hospital,,50146.0,9927.0,CITY OF HOPE NATIONAL MEDICAL CTR,,,,,,,1500 E Duarte Rd,,Duarte,CA,91010,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,1094225.0,1669589537.0,SANJEET,,DADWAL,,1500 E DUARTE RD,1500 E DUARTE RD,DUARTE,CA,91010,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease,,,,,,CA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Merck Sharp & Dohme Corporation,100000000053,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Drug,INFECTIOUS DISEASE,PREVYMIS,0006-5004-01,,,,,,,,,,,,,,,,,,,,,,,,,,0.6,08/10/2020,In-kind items and services,,,,,,,No,No,"A Phase 3 randomized, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of letermovir LET prophylaxis when extended from 100 days to 200 days post transplant in cytomegalovirus CMV seropositive recipients R of an allogenic hematopoietic stem cell transplant HSCT",No,740741735,2020,01/20/2023,,,Equipment or non-drug supplies provided to a clinical study site.
4043,UNCHANGED,Covered Recipient Teaching Hospital,,160058.0,9253.0,University Of Iowa Hosp & Clinics,,,,,,,200 Hawkins Drive,,Iowa City,IA,52242,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,1162089.0,1053520759.0,ALICIA,K,GERKE,,200 HAWKINS DR,,IOWA CITY,IA,52242-1009,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease,,,,,,IA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Boehringer Ingelheim USA, Inc.",100000010823,Boehringer Ingelheim Pharma GmbH & Co.KG,,Germany,Yes,Covered,Drug,RESPIRATORY,OFEV,0597-0143-60,,,,,,,,,,,,,,,,,,,,,,,,,,62.2,10/01/2020,In-kind items and services,,,,,,,No,No,Extension,No,750752469,2020,01/20/2023,,,
8698,UNCHANGED,Covered Recipient Teaching Hospital,,440039.0,9077.0,VANDERBILT UNIVERSITY MEDICAL CENTER,,,,,,,1211 Medical Center Drive,,Nashville,TN,37232,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,720090.0,1528025715.0,DOUGLAS,,SEIDNER,,3601 THE VANDERBILT CLINIC,,NASHVILLE,TN,37232-0001,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology,,,,,,TN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Takeda Pharmaceuticals U.S.A., Inc.",100000000337,"Takeda Pharmaceuticals U.S.A., Inc.",IL,United States,Yes,Covered,Drug,INTERNAL MEDICINE,GATTEX,68875-0101-2,,,,,,,,,,,,,,,,,,,,,,,,,,609.3,01/28/2020,Cash or cash equivalent,,,,,,,No,No,"A PROSPECTIVE, MULTI-CENTER REGISTRY FOR PATIENTS WITH SHORT BOWEL SYNDROME",No,737066085,2020,01/20/2023,,,
8132,UNCHANGED,Covered Recipient Teaching Hospital,,190064.0,9615.0,Our Lady Of The Lake Rmc Amended,,,,,,,5000 HENNESSY BLVD,,BATON ROUGE,LA,70808,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,1146967.0,1518962653.0,JAMES,E.,CRAVEN,IV,7777 HENNESSY BLVD STE 1008,,BATON ROUGE,LA,70808-4368,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Surgery|Vascular Surgery,,,,,,LA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Endologix, LLC",100000000079,"Endologix, LLC",CA,United States,Yes,Covered,Device,Cardiology/Vascular Diseases,AFX,,,,,,,,,,,,,,,,,,,,,,,,,,,242.0,04/09/2020,Cash or cash equivalent,,,,,,,No,No,Leopard Study,No,722702777,2020,01/20/2023,,,
2222,UNCHANGED,Covered Recipient Teaching Hospital,,110010.0,9427.0,EMORY UNIVERSITY HOSPITAL,,,,,,,1364 Clifton Rd Ne,,Atlanta,GA,30322,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,789134.0,1952358582.0,JAMES,,LAH,,12 EXECUTIVE PARK DR NE,,ATLANTA,GA,30329-2206,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology,,,,,,GA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,AbbVie Inc.,100000000204,AbbVie Inc.,IL,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,10199.8,12/02/2020,Cash or cash equivalent,,,,,,,No,No,M15-566,No,721137925,2020,01/20/2023,NCT02880956,,
8914,UNCHANGED,Covered Recipient Teaching Hospital,,390028.0,8923.0,Upmc Mercy Hospital,,,,,,,1400 Locust St,,Pittsburgh,PA,15219,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,347278.0,1649242033.0,SILVA,A,ARSLANIAN,,5230 CENTRE AVE,FL 2,PITTSBURGH,PA,15232,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine,,,,,,PA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Novo Nordisk Inc,100000000163,Novo Nordisk AS,,Denmark,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.56,11/17/2020,In-kind items and services,,,,,,,No,No,NN9536-4451,No,742324399,2020,01/20/2023,,,
8307,UNCHANGED,Covered Recipient Physician,,,,,122292.0,1699720151.0,VERA,A.,BITTNER,,1530 3rd Ave S,,Birmingham,AL,35294,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease,,,,,,AL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Sanofi and Genzyme US Companies,100000000076,SANOFI-AVENTIS U.S. LLC,NJ,United States,Yes,Covered,Biological,Cardiology/Vascular Diseases,PRALUENT,0024-5901-00,,,,,,,,,,,,,,,,,,,,,,,,,,167.37,02/14/2020,In-kind items and services,,,,,,,No,No,ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab,No,744030597,2020,01/20/2023,,,
4431,UNCHANGED,Covered Recipient Teaching Hospital,,54144.0,9918.0,Langley Porter Psychiatric Hospital,,,,,,,401 PARNASSUS AVE,,SAN FRANCISCO,CA,94143,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,167563.0,1699706812.0,ADIL,I.,DAUD,,1600 DIVISADERO ST,FL 2,SAN FRANCISCO,CA,94115,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,,,,,,CA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Incyte Corporation,100000000263,Incyte Corporation,DE,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2809.8,10/06/2020,Cash or cash equivalent,,,,,,,No,No,A Phase 2 Study of INCMGA00012 in Participants With Metastatic Merkel Cell Carcinoma,No,744303043,2020,01/20/2023,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
7672,UNCHANGED,Covered Recipient Teaching Hospital,,220110.0,8641.0,Brigham And Womens Hospital,,,,,,,75 FRANCIS ST,,BOSTON,MA,02115,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,290720.0,1417983172.0,KEVIN,JAMES,CROCE,,75 FRANCIS ST,PBB-1,BOSTON,MA,02115,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease,,,,,,MA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,BIOTRONIK INC.,100000010579,BIOTRONIK INC.,OR,United States,Yes,Covered,Device,Cardiology/Vascular Diseases,Orsiro,,,,,,,,,,,,,,,,,,,,,,,,,,,82.88,09/09/2020,Cash or cash equivalent,,,,,,,No,No,BIOFLOW-VII,No,751883847,2020,01/20/2023,,,
1424,UNCHANGED,Covered Recipient Teaching Hospital,,100271.0,9478.0,H. LEE MOFFITT CANCER CENTER,,,,,,,12902 Magnolia Dr,,Tampa,FL,33612,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,918668.0,1518129121.0,FREDERICK,,LOCKE,,12902 USF MAGNOLIA DR,,TAMPA,FL,33612,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,,,,,,FL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Kite Pharma, Inc.",100000216809,"Kite Pharma, Inc.",CA,United States,Yes,Covered,Drug,CELLT,Yescarta,71287-119-02,,,,,,,,,,,,,,,,,,,,,,,,,,49520.0,09/22/2020,Cash or cash equivalent,,,,,,,No,No,"A Multicenter, Open-label, Expanded Access Study of Axicabtagene Ciloleucel for the Treatment of Subjects with Relapsed/Refractory Large B-cell Lymphoma (ZUMA 9)",No,732772601,2020,01/20/2023,,,;KTE-C19-109;KP23912;KPCROS;593238634;10656014
7323,UNCHANGED,Covered Recipient Teaching Hospital,,50396.0,9925.0,Santa Barbara Cottage Hospital,,,,,,,400 West Pueblo,,Santa Barbara,CA,93105,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,273034.0,1023122587.0,JOSEPH,R,ARAGON,,317 W PUEBLO ST,,SANTA BARBARA,CA,93105,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Interventional Cardiology,,,,,,CA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Abbott Laboratories,100000010680,Abbott Laboratories,IL,United States,Yes,Covered,Device,Cardiac Arrhythmias and Heart Failure,Xience V Coronary Stent System,,,,,,,,,,,,,,,,,,,,,,,,,,,10101.25,01/22/2020,Cash or cash equivalent,,,,,,,No,No,XIENCE 28 USA Study,No,751746633,2020,01/20/2023,NCT03815175,,XIENCE ST DAPT 28 US
9773,UNCHANGED,Covered Recipient Teaching Hospital,,220162.0,8640.0,Dana-Farber Cancer Institute,,,,,,,450 BROOKLINE AVE,,BOSTON,MA,02215,United States,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Bristol Myers Squibb Company,100000005499,"E.R. Squibb & Sons, L.L.C.",NJ,United States,Yes,Covered,Biological,Oncology,OPDIVO,0003-3774-12,,,,,,,,,,,,,,,,,,,,,,,,,,180592.0,03/25/2020,Cash or cash equivalent,,,,,,,No,No,I-O CC Seattle Genetics Phase IIa combo in NHL nivo brentuximab,No,736758185,2020,01/20/2023,,,
1810,UNCHANGED,Covered Recipient Teaching Hospital,,410007.0,8664.0,Rhode Island Hospital,,,,,,,593 Eddy Street,,Providence,RI,02903,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,275388.0,1063533875.0,JOHN,MICHAEL,CAHILL,,600 MOYE BLVD,,GREENVILLE,NC,27834,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease,,,,,,NC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Abbott Laboratories,100000010680,Abbott Laboratories,IL,United States,Yes,Covered,Device,Vascular,Xience Sierra Coronary Stent System,,,,,,,,,,,,,,,,,,,,,,,,,,,850.0,01/17/2020,Cash or cash equivalent,,,,,,,No,No,XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients,No,749808819,2020,01/20/2023,NTC03218787,,XIENCE
1027,UNCHANGED,Covered Recipient Teaching Hospital,,380009.0,9844.0,Ohsu Hospital And Clinics,,,,,,,3181 Sw Sam Jackson Park Rd,,Portland,OR,97239,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,786371.0,1851462998.0,JACQUELINE,,VUKY,,1130 NW 22ND AVE,SUITE 100,PORTLAND,OR,97210,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,,,,,,OR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"EMD Serono, Inc.",100000000127,"EMD Serono, Inc.",MA,United States,Yes,Covered,Drug,Oncology,Avelumab,44087-3535-1,,,,,,,,,,,,,,,,,,,,,,,,,,637.0,07/01/2020,Cash or cash equivalent,,,,,,,No,No,MS100070_0176,No,749599483,2020,01/20/2023,,,
640,UNCHANGED,Covered Recipient Teaching Hospital,,390256.0,8937.0,Milton S. Hershey Medical Center,,,,,,,500 UNIVERSITY DR,,HERSHEY,PA,17033,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,161214.0,1558324285.0,ANDREA,L.,ZAENGLEIN,,500 UNIVERSITY DR,STE 100,HERSHEY,PA,17033,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Dermatology,,,,,,PA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Incyte Corporation,100000000263,Incyte Corporation,DE,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,45.6,01/09/2020,Cash or cash equivalent,,,,,,,No,No,"An Open Label, Pilot Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis",No,744313633,2020,01/20/2023,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
6975,UNCHANGED,Covered Recipient Teaching Hospital,,110010.0,9427.0,EMORY UNIVERSITY HOSPITAL,,,,,,,1364 CLIFTON RD NE,,ATLANTA,GA,30322,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,445786.0,1891723912.0,IHAB,,HAJJAR,,12 EXECUTIVE PARK DR NE,,ATLANTA,GA,30329,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Geriatric Medicine,,,,,,GA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Genentech, Inc.",100000000089,"Genentech, Inc.",CA,United States,Yes,Non-Covered,Drug,None,Non-Covered Product,,,,,,,,,,,,,,,,,,,,,,,,,,,38409.0,03/16/2020,Cash or cash equivalent,,,,,,,No,No,GANTENERUMAB IN EARLY AD,No,742999477,2020,01/20/2023,,,
4304,UNCHANGED,Covered Recipient Teaching Hospital,,300003.0,8626.0,MARY HITCHCOCK MEMORIAL HOSP,,,,,,,One Medical Center Dr,,Lebanon,NH,03756,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,168064.0,1700992583.0,WILLIAM,F C,RIGBY,,1 MEDICAL CENTER DR,DHMC RHEUMATOLOGY,LEBANON,NH,03756-1000,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology,,,,,,NH,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,AbbVie Inc.,100000000204,AbbVie Inc.,IL,United States,Yes,Covered,Drug,IMMUNOLOGY,RINVOQ,0074-2306-30,,,,,,,,,,,,,,,,,,,,,,,,,,617.16,05/19/2020,Cash or cash equivalent,,,,,,,No,No,M15-555,No,721133969,2020,01/20/2023,NCT02706951,,
765,UNCHANGED,Covered Recipient Teaching Hospital,,310015.0,9357.0,Morristown Medical Center,,,,,,,100 Madison Ave,,Morristown,NJ,07960,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,332771.0,1336113653.0,LAWRENCE,A,SILVERMAN,,100 MADISON AVE,# 309C,MORRISTOWN,NJ,07960,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Endocrinology,,,,,,NJ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Novo Nordisk Inc,100000000163,Novo Nordisk AS,,Denmark,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,3.25,01/03/2020,In-kind items and services,,,,,,,No,No,NN8640-4263,No,742309215,2020,01/20/2023,,,
8288,UNCHANGED,Covered Recipient Teaching Hospital,,190005.0,8938.0,UNIVERSITY MEDICAL CTR. AT NEW ORLEA,,,,,,,2000 Canal St,,New Orleans,LA,70112,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,269798.0,1942258116.0,AGUSTIN,,GARCIA,,52579 HIGHWAY 51 S,52579 HIGHWAY 51 S,INDEPENDENCE,LA,70443-2231,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,,,,,,CA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Merck Sharp & Dohme Corporation,100000000053,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Biological,ONCOLOGY,KEYTRUDA,0006-3029-02,,,,,,,,,,,,,,,,,,,,,,,,,,236.4,06/26/2020,Cash or cash equivalent,,,,,,,No,No,"A Multicenter, Open-label, Randomized, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib in Combination with Pembrolizumab Versus Treatment of Physician s Choice in  Subjects with Advanced Endometrial Cancer",No,740792201,2020,01/20/2023,,,
258,UNCHANGED,Covered Recipient Teaching Hospital,,224007.0,8643.0,Mclean Hospital,,,,,,,115 MILL ST,,BELMONT,MA,02478,United States,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Alkermes, Inc.",100000000255,"Alkermes, Inc.",MA,United States,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,24989.5,01/21/2020,Cash or cash equivalent,,,,,,,Yes,No,,No,724178911,2020,01/20/2023,,,
2101,UNCHANGED,Covered Recipient Teaching Hospital,,190036.0,9618.0,OCHSNER CLINIC FOUNDATION,,,,,,,1516 Jefferson Hwy,,New Orleans,LA,70121,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,243253.0,1376507418.0,HERSCHEL,DAVID,VARGAS,,1514 JEFFERSON HWY,,NEW ORLEANS,LA,70121-2429,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Colon & Rectal Surgery,,,,,,KY,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Takeda Pharmaceuticals U.S.A., Inc.",100000000337,"Takeda Pharmaceuticals U.S.A., Inc.",IL,United States,Yes,Covered,Drug,INTERNAL MEDICINE,GATTEX,68875-0101-2,,,,,,,,,,,,,,,,,,,,,,,,,,761.0,10/22/2020,Cash or cash equivalent,,,,,,,No,No,"A PROSPECTIVE, MULTI-CENTER REGISTRY FOR PATIENTS WITH SHORT BOWEL SYNDROME",No,737063421,2020,01/20/2023,,,
8201,UNCHANGED,Covered Recipient Physician,,,,,276270.0,1083614879.0,ILEANA,JOSEFINA,TANDRON,,2240 GAUSE BLVD E,,SLIDELL,LA,70461,United States,,,Medical Doctor,,,,,,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",,,,,,LA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Novo Nordisk AS,100000000163,Novo Nordisk AS,,Denmark,Yes,Covered,Drug,Diabetes,RYBELSUS,0169-4303-13,,,,,,,,,,,,,,,,,,,,,,,,,,16.0,12/10/2020,In-kind items and services,,,,,,,No,No,EX9924-4473,No,822177371,2020,01/20/2023,,,
9665,UNCHANGED,Covered Recipient Teaching Hospital,,230053.0,9153.0,Henry Ford Hospital,,,,,,,2799 W GRAND BLVD,,DETROIT,MI,48202,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,687946.0,1386762565.0,JENNIFER,A.,COWGER,,2799 W Grand Blvd,Ste K14,Detroit,MI,48202,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Advanced Heart Failure and Transplant Cardiology,,,,,,IN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Medtronic Vascular, Inc.",100000010384,"Medtronic Vascular, Inc.",MN,United States,Yes,Covered,Device,Ventricular Assist Devices,HeartWare HVAD,,,,,,,,,,,,,,,,,,,,,,,,,,,2169.0,04/21/2020,Cash or cash equivalent,,,,,,,No,No,PSR-MCS,No,728060025,2020,01/20/2023,,,
1968,UNCHANGED,Covered Recipient Teaching Hospital,,310015.0,9357.0,MORRISTOWN MEDICAL CENTER,,,,,,,100 Madison Ave,,Morristown,NJ,07960,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,483232.0,1205905379.0,SANDIP,M,PRASAD,,171 ASHLEY AVE,171 ASHLEY AVE,CHARLESTON,SC,29425-8908,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Urology,,,,,,IL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Merck Sharp & Dohme Corporation,100000000053,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Biological,ONCOLOGY,KEYTRUDA,0006-3029-02,,,,,,,,,,,,,,,,,,,,,,,,,,29.7,08/10/2020,In-kind items and services,,,,,,,No,No,"A Phase 3, Randomized, Comparator-controlled Clinical Trial to Study the Efficacy and Safety of Pembrolizumab MK-3475 in Combination with Bacillus Calmette- Guerin BCG in Participants with High-risk Non-muscle Invasive Bladder Cancer HR NMIBC that is either Persistent or Recurrent Following BCG Induction or that is Na ve to BCG Treatment KEYNOTE-676",No,740822739,2020,01/20/2023,,,Equipment or non-drug supplies provided to a clinical study site.
1935,UNCHANGED,Covered Recipient Teaching Hospital,,50047.0,9847.0,CALIFORNIA PACIFIC MEDICAL CENTER,,,,,,,2333 BUCHANAN STREET,,SAN FRANCISCO,CA,94115,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,180463.0,1962596551.0,JOHN,K,CHAN,,475 BRANNAN ST,,SAN FRANCISCO,CA,94107,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Obstetrics & Gynecology|Gynecologic Oncology,,,,,,CA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Genentech, Inc.",100000000089,"Genentech, Inc.",CA,United States,Yes,Covered,Biological,BioOncology,Avastin,50242-061-01,,Covered,Biological,BioOncology,TECENTRIQ,50242-917-01,,Non-Covered,Drug,None,Non-Covered Product,,,,,,,,,,,,,,,1532.68,11/05/2020,Cash or cash equivalent,,,,,,,No,No,A PHASE III MULTICENTER RANDOMIZED PLACEBO CONTROLLED STUDY OF ATEZOLIZUMAB VERSUS PLACEBO IN COM,No,742994341,2020,01/20/2023,,,
9334,UNCHANGED,Covered Recipient Teaching Hospital,,230297.0,8803.0,Karmanos Cancer Hospital,,,,,,,4100 John R St,,Detroit,MI,48201,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,945091.0,1437446820.0,Hirva,Mansurali,Mamdani,,4100 John R St,--,Detroit,MI,48201,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,,,,,,IN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,AstraZeneca Pharmaceuticals LP,100000000146,AstraZeneca Pharmaceuticals LP,DE,United States,Yes,Covered,Drug,Oncology,IMFINZI,0310-4500-12,,,,,,,,,,,,,,,,,,,,,,,,,,13648.0,04/30/2020,Cash or cash equivalent,,,,,,,No,No,"A Phase III, Randomized, Placebo-controlled, Double-blind, Multi-center, International Study of Durvalumab Following Stereotactic Body Radiation Therapy (SBRT) for the Treatment of Patients with unresected Stage I/II, lymph-node negative Non-small Cell Lung Cancer (PACIFIC-4/RTOG-3515)",No,736736751,2020,01/20/2023,,,
4358,UNCHANGED,Covered Recipient Teaching Hospital,,220162.0,8640.0,Dana-Farber Cancer Institute,,,,,,,450 Brookline Ave,,Boston,MA,02215,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,319725.0,1053393496.0,PATRICK,,WEN,,75 FRANCIS ST,,BOSTON,MA,02115-6110,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology,,,,,,MA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Agios Pharmaceuticals, Inc.",100000181751,"Agios Pharmaceuticals, Inc.",MA,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,8588.97,01/07/2020,Cash or cash equivalent,,,,,,,No,No,"A Phase I, Multicenter, Open-Label, Dose-Escalation and Expansion, Safety, Pharmacokinetic, Pharmacodynamic, and Clinical Activity Study of Orally Administered AG-881 in Patients With Advanced Hematologic Malignancies With an IDH1 and/or IDH2 Mutation",No,752073343,2020,01/20/2023,,,
2706,UNCHANGED,Covered Recipient Teaching Hospital,,450044.0,9703.0,UT SOUTHWESTERN UNIVERSITY HOSP,,,,,,,6201 Harry Hines Blvd,,Dallas,TX,75390,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,343635.0,1568429934.0,DAVID,S,MILLER,,5323 HARRY HINES BLVD,5323 HARRY HINES BLVD,DALLAS,TX,75390-7208,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Obstetrics & Gynecology|Gynecologic Oncology,,,,,,TX,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Merck Sharp & Dohme Corporation,100000000053,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Drug,ONCOLOGY,LENVIMA,62856-712-30,,,,,,,,,,,,,,,,,,,,,,,,,,76.7,05/28/2020,In-kind items and services,,,,,,,No,No,"A Phase 3 Randomized, Open-Label, Study of Pembrolizumab MK-3475 Plus Lenvatinib E7080,MK-7902 Versus Chemotherapy for First-line Treatment of Advanced or Recurrent Endometrial Carcinoma LEAP-001",No,740799615,2020,01/20/2023,,,Equipment or non-drug supplies provided to a clinical study site.
8166,UNCHANGED,Covered Recipient Teaching Hospital,,440039.0,9077.0,Vanderbilt University Medical Center,,,,,,,1211 Medical Center Drive,,Nashville,TN,37232,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,683434.0,1235226358.0,KEVIN,D,NISWENDER,,1310 24TH AVE S,# 119,NASHVILLE,TN,37212,United States,,,Medical Doctor,,,,,,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",,,,,,TN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Novo Nordisk Inc,100000000163,Novo Nordisk AS,,Denmark,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,645.0,11/30/2020,Cash or cash equivalent,,,,,,,No,No,NN9536-4373,No,742364939,2020,01/20/2023,,,
7470,UNCHANGED,Covered Recipient Teaching Hospital,,63301.0,9762.0,CHILDRENS HOSPITAL COLORADO,,,,,,,13123 East 16th Avenue,,Aurora,CO,80045,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,330900.0,1285650150.0,Shawn,,McCandless,,13123 East 16th Avenue,,Aurora,CO,80045,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Medical Genetics|Clinical Genetics (M.D.),,,,,,CO,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Soleno Therapeutics, Inc.",100000196839,"Soleno Therapeutics, Inc.",CA,United States,Yes,Covered,Drug,Diazoxide Choline Controlled Release (DCCR),Diazoxide Choline Controlled Release (DCCR),,,,,,,,,,,,,,,,,,,,,,,,,,,91594.81,08/31/2020,Cash or cash equivalent,,,,,,,No,No,"A Randomized, Double-Blind, Placebo-Controlled Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients with Prader-Willi Syndrome",No,750532747,2020,01/20/2023,NCT03440814,,
721,UNCHANGED,Covered Recipient Teaching Hospital,,340001.0,9398.0,Carolinas Healthcare System Northeas,,,,,,,920 CHURCH ST N,,CONCORD,NC,28025,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,492182.0,1518965607.0,ASIM,,AMIN,,1021 Morehead Medical Dr,,Charlotte,NC,28204,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,,,,,,NC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Bristol Myers Squibb Company,100000005499,"E.R. Squibb & Sons, L.L.C.",NJ,United States,Yes,Covered,Biological,Oncology,OPDIVO,0003-3774-12,,,,,,,,,,,,,,,,,,,,,,,,,,39894.28,05/08/2020,Cash or cash equivalent,,,,,,,No,No,"Phase III MEL 1L, PD-1 vs Ipi vs. PD-1 Ipi",No,736758425,2020,01/20/2023,,,
7250,UNCHANGED,Covered Recipient Teaching Hospital,,490063.0,9377.0,INOVA FAIRFAX HOSPITAL,,,,,,,3300 Gallows Rd,,Falls Church,VA,22042,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,198761.0,1376701946.0,JEANNY,B,ARAGON-CHING,,2150 PENNSYLVANIA AVE NW,2150 PENNSYLVANIA AVE NW,WASHINGTON,DC,20037-3201,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,,,,,,DC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Merck Sharp & Dohme Corporation,100000000053,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Biological,ONCOLOGY,KEYTRUDA,0006-3029-02,,,,,,,,,,,,,,,,,,,,,,,,,,5.31,05/08/2020,In-kind items and services,,,,,,,No,No,"A Phase 3, Randomized Double Blind Study to Evaluate Peri-operative Pembrolizumab MK-3475  Neoadjuvant Chemotherapy versus Perioperative Placebo  Neoadjuvant Chemotherapy in Cisplatin-Eligible Participants with Muscle-invasive Bladder Cancer KEYNOTE-866",No,740794765,2020,01/20/2023,,,Equipment or non-drug supplies provided to a clinical study site.
7589,UNCHANGED,Covered Recipient Teaching Hospital,,220116.0,8657.0,Tufts Medical Center,,,,,,,800 Washington St,Box 018,Boston,MA,02111,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,1312084.0,1043555139.0,CINDY,,VARGA,,830 HARRISON AVE,,BOSTON,MA,02118-2905,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,,,,,,MA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Janssen Research & Development, LLC",100000005592,"Janssen Research & Development, LLC",NJ,United States,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,4820.0,06/08/2020,Cash or cash equivalent,,,,,,,No,No,"A Phase 3 Study Comparing Daratumumab, VELCADE (bortezomib), Lenalidomide, and Dexamethasone (D-VRd) with VELCADE, Lenalidomide, and Dexamethasone (VRd) in Subjects with Untreated Multiple Myeloma and for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial Therapy",No,719480001,2020,01/20/2023,,,
4837,UNCHANGED,Covered Recipient Teaching Hospital,,380009.0,9844.0,Ohsu Hospital And Clinics,,,,,,,3181 Sw Sam Jackson Park Rd,,Portland,OR,97239,United States,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Travere Therapeutics, Inc.",100000061305,"Travere Therapeutics, Inc.",CA,United States,Yes,Covered,Drug,Hepatology,(810) Chenodal,45043-0876-4,,,,,,,,,,,,,,,,,,,,,,,,,,255.0,03/11/2020,Cash or cash equivalent,Other,,,,,,No,No,Protocol No: 018CTXX15001,No,734747865,2020,01/20/2023,,,
2843,UNCHANGED,Covered Recipient Teaching Hospital,,160058.0,9253.0,University Of Iowa Hosp & Clinics,,,,,,,200 HAWKINS DR,,IOWA CITY,IA,52242,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,613414.0,1790772846.0,PETAR,S.,LENERT,,200 Hawkins Dr,,Iowa City,IA,52242,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine,,,,,,IA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Sanofi and Genzyme US Companies,100000000067,SANOFI US SERVICES INC.,NJ,United States,Yes,Covered,Biological,Immunology,KEVZARA,0024-5908-01,,,,,,,,,,,,,,,,,,,,,,,,,,13835.28,02/10/2020,Cash or cash equivalent,,,,,,,No,No,"A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Sarilumab in Patients With Polymyalgia Rheumatica",No,744083681,2020,01/20/2023,NCT03600818,,
5094,UNCHANGED,Covered Recipient Teaching Hospital,,50047.0,9847.0,CALIFORNIA PACIFIC MEDICAL CENTER,,,,,,,2333 BUCHANAN STREET,,SAN FRANCISCO,CA,94115,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,180463.0,1962596551.0,JOHN,K,CHAN,,475 BRANNAN ST,,SAN FRANCISCO,CA,94107,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Obstetrics & Gynecology|Gynecologic Oncology,,,,,,CA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Genentech, Inc.",100000000089,"Genentech, Inc.",CA,United States,Yes,Covered,Biological,BioOncology,Avastin,50242-061-01,,Covered,Biological,BioOncology,TECENTRIQ,50242-917-01,,Non-Covered,Drug,None,Non-Covered Product,,,,,,,,,,,,,,,12615.78,08/27/2020,Cash or cash equivalent,,,,,,,No,No,A PHASE III MULTICENTER RANDOMIZED PLACEBO CONTROLLED STUDY OF ATEZOLIZUMAB VERSUS PLACEBO IN COM,No,742994367,2020,01/20/2023,,,
2768,UNCHANGED,Covered Recipient Physician,,,,,204864.0,1528270808.0,EVANTHIA,,BERNITSAS,,8D UNIVERSITY HEALTH CENTER  4201 ST ANTOINE,,DETROIT,MI,48201,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology,,,,,,MI,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Genentech, Inc.",100000005656,F. Hoffmann-La Roche AG,,Switzerland,Yes,Covered,Biological,Immunology,Ocrevus,50242-150-01,,,,,,,,,,,,,,,,,,,,,,,,,,1164.39,09/30/2020,In-kind items and services,,,,,,,No,No,"AN OPEN-LABEL, MULTICENTER STUDY TO ASSESS DISEASE ACTIVITY AND BIOMARKERS OF NEURONAL DAMAGE IN MINORITY PATIENTS WITH RELAPSING MULTIPLE SCLEROSIS RECEIVING TREATMENT WITH OCRELIZUMAB",No,742979941,2020,01/20/2023,,,
361,UNCHANGED,Covered Recipient Teaching Hospital,,380103.0,9852.0,Kaiser Westside Medical Center,,,,,,,2875 NW STUCKI AVE.,,HILLSBORO,OR,97124,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,1324585.0,1790934149.0,ABDUL HAI,,MANSOOR,,10180 SE Sunnyside Rd,,Clackamas,OR,97015-8970,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine,,,,,,OR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Karyopharm Therapeutics Inc.,100000806841,Karyopharm Therapeutics Inc.,MA,United States,Yes,Covered,Drug,Oncology,XPOVIO,72237-101-01,,,,,,,,,,,,,,,,,,,,,,,,,,14040.0,12/29/2020,Cash or cash equivalent,,,,,,,No,No,KCP-330-023,No,752652125,2020,01/20/2023,,,
6556,UNCHANGED,Covered Recipient Teaching Hospital,,53302.0,9932.0,Childrens Hospital Los Angeles,,,,,,,4650 W Sunset Blvd,,Los Angeles,CA,90027,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,1163607.0,1114018694.0,Hisham,Mohamed,Abdel-Azim,,4650 W Sunset Blvd,,Los Angeles,CA,90027,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Hematology-Oncology,,,,,,CA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Adaptive Biotechnologies Corporation,100000486814,Adaptive Biotechnologies Corporation,WA,United States,Yes,Covered,Device,B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA,clonoSEQ,,,,,,,,,,,,,,,,,,,,,,,,,,,450.0,08/07/2020,In-kind items and services,Patient Care,,,,,,No,No,PBMTC-ONC-1701,No,752361553,2020,01/20/2023,,,
5241,UNCHANGED,Covered Recipient Teaching Hospital,,63301.0,9762.0,Childrens Hospital Colorado,,,,,,,13123 E 16TH AVE,B010,AURORA,CO,80045,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,438563.0,1649354150.0,ANNA,,BRUCKNER,,13123 E 16TH AVE,,AURORA,CO,80045-7106,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Dermatology|Pediatric Dermatology,,,,,,CA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Amryt Pharma Holdings Ltd,100000576811,Amryt Pharma Holdings Ltd,,Ireland,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1890.0,10/14/2020,Cash or cash equivalent,,,,,,,No,No,"Double Blind, Randomised, Vehicle Controlled, Phase III, Efficacy and Safety Study With 24-month Open-label Follow up of Oleogel-S10 in Patients With Inherited Epidermolysis Bullosa",No,721461049,2020,01/20/2023,,,
2591,UNCHANGED,Covered Recipient Physician,,,,,242686.0,1356357651.0,MARTIN,J,VALENTE,,801 S MILWAUKEE AVE,,LIBERTYVILLE,IL,60048-3204,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Anesthesiology,,,,,,IL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,AbbVie Inc.,100000000204,AbbVie Inc.,IL,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,660.0,12/17/2020,Cash or cash equivalent,,,,,,,No,No,M19-034,No,721143549,2020,01/20/2023,,,
7297,UNCHANGED,Covered Recipient Physician,,,,,333790.0,1376523746.0,LAWRENCE,H,SCHWARTZ,,1275 YORK AVE,,NEW YORK,NY,10021-6007,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Radiology|Diagnostic Radiology,,,,,,NY,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Regeneron Pharmaceuticals, Inc.",100000000069,"Regeneron Pharmaceuticals, Inc.",NY,United States,Yes,Covered,Biological,ONCOLOGY,LIBTAYO,61755-008-01,,,,,,,,,,,,,,,,,,,,,,,,,,5000.0,02/18/2020,Cash or cash equivalent,,,,,,,No,No,"A PHASE 2 STUDY OF REGN2810, A FULLY HUMAN MONOCLONAL ANTIBODY TO PROGRAMMED DEATH-1, IN PATIENTS WITH ADVANCED BASAL CELL CARCINOMA WHO EXPERIENCED PROGRESSION OF DISEASE ON HEDGEHOG PATHWAY INHIBITOR THERAPY, OR WERE INTOLERANT OF PRIOR HEDGEHOG PATHWAY INHIBITOR THERAPY",No,724436603,2020,01/20/2023,NCT03132636,,
2228,UNCHANGED,Covered Recipient Teaching Hospital,,450076.0,9670.0,UT MD ANDERSON CANCER CENTER,,,,,,,1515 Holcombe Blvd,,Houston,TX,77030,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,349618.0,1700979275.0,ARLENE,O,SIEFKER-RADTKE,,1515 HOLCOMBE BLVD,1515 HOLCOMBE BLVD,HOUSTON,TX,77030-4009,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,,,,,,TX,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Merck Sharp & Dohme Corporation,100000000053,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Biological,ONCOLOGY,KEYTRUDA,0006-3029-02,,,,,,,,,,,,,,,,,,,,,,,,,,0.99,11/09/2020,In-kind items and services,,,,,,,No,No,"A Phase 3, Randomized Double Blind Study to Evaluate Peri-operative Pembrolizumab MK-3475  Neoadjuvant Chemotherapy versus Perioperative Placebo  Neoadjuvant Chemotherapy in Cisplatin-Eligible Participants with Muscle-invasive Bladder Cancer KEYNOTE-866",No,740785013,2020,01/20/2023,,,Equipment or non-drug supplies provided to a clinical study site.
2401,UNCHANGED,Covered Recipient Teaching Hospital,,50660.0,9922.0,USC NORRIS CANCER HOSPITAL,,,,,,,1441 Eastlake Ave,,Los Angeles,CA,90089,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,428589.0,1316104797.0,SARMAD,,SADEGHI,,1441 EASTLAKE AVE,1441 EASTLAKE AVE,LOS ANGELES,CA,90089-0112,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology,,,,,,CA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Merck Sharp & Dohme Corporation,100000000053,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Biological,ONCOLOGY,KEYTRUDA,0006-3029-02,,,,,,,,,,,,,,,,,,,,,,,,,,249999.91,02/12/2020,Cash or cash equivalent,,,,,,,No,No,"A Phase II trial of sEphB4-HSA in combination with Anti PD1 Antibody Pembrolizumab, MK-7435 for metastatic urothelial cancer refractory to platinum and at least one other agent.",No,740847847,2020,01/20/2023,,,
8138,UNCHANGED,Covered Recipient Physician,,,,,62644.0,1376572784.0,ANNE,L.,PETERS,,9033 Wilshire Blvd Ste 406,,Beverly Hills,CA,90211,United States,,,Medical Doctor,,,,,,"Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism",,,,,,CA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Sanofi and Genzyme US Companies,100000000076,SANOFI-AVENTIS U.S. LLC,NJ,United States,Yes,Covered,Biological,Endocrinology,TOUJEO,0024-5869-03,,,,,,,,,,,,,,,,,,,,,,,,,,618.46,06/12/2020,In-kind items and services,,,,,,,No,No,"Multinational, cross-sectional, observational study to describe glycemic control and quality of life for type 1 diabetic adult patients",No,744030491,2020,01/20/2023,,,
7708,UNCHANGED,Covered Recipient Teaching Hospital,,490063.0,9377.0,INOVA FAIRFAX HOSPITAL,,,,,,,3300 Gallows Rd,,Falls Church,VA,22042,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,198761.0,1376701946.0,JEANNY,B,ARAGON-CHING,,2150 PENNSYLVANIA AVE NW,2150 PENNSYLVANIA AVE NW,WASHINGTON,DC,20037-3201,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,,,,,,DC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Merck Sharp & Dohme Corporation,100000000053,Merck Sharp & Dohme Corporation,NJ,United States,Yes,Covered,Biological,ONCOLOGY,KEYTRUDA,0006-3029-02,,,,,,,,,,,,,,,,,,,,,,,,,,34687.77,12/28/2020,In-kind items and services,,,,,,,No,No,"A Phase 3, Randomized, Double-blind Trial of Pembrolizumab MK-3475 Plus Enzalutamide Plus ADT Versus Placebo Plus Enzalutamide Plus ADT in Participants With Metastatic Hormone-Sensitive Prostate Cancer mHSPC KEYNOTE-991",No,740782979,2020,01/20/2023,,,Study drug provided to a clinical study site.
8529,UNCHANGED,Covered Recipient Teaching Hospital,,220086.0,8638.0,BETH ISRAEL DEACONESS MEDICAL CENTER,,,,,,,330 BROOKLINE AVENUE,,BOSTON,MA,02215,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,2792106.0,1053605477.0,ZHENGHUI,GORDON,JIANG,,110 FRANCIS STREET SUITE 8E,,BOSTON,MA,02215,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Transplant Hepatology,,,,,,MA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Pfizer Inc.,100000000286,PFIZER INC.,NY,United States,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,70083.0,09/28/2020,Cash or cash equivalent,,,,,,,No,No,MECHANISTIC INVESTIGATION OF CARDIOVASCULAR DISEASE IN NAFLD,No,742880961,2020,01/20/2023,,,
6621,UNCHANGED,Covered Recipient Teaching Hospital,,220162.0,8640.0,Dana-Farber Cancer Institute,,,,,,,450 BROOKLINE AVE,,BOSTON,MA,02215,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,183394.0,1033137864.0,LEWIS,,SILVERMAN,,1 GUSTAVE L LEVY PL,,NEW YORK,NY,10029,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology,,,,,,NY,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Incyte Corporation,100000000263,Incyte Corporation,DE,United States,Yes,Non-Covered,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,37.08,02/10/2020,Cash or cash equivalent,,,,,,,No,No,"A Pilot Study of the Immunological Effects of Neo Adjuvant INCB024360 in Patients with Epithelial Ovarian, Fallopian Tube or Primary CITN-05 Peritoneal Carcinoma",No,744295151,2020,01/20/2023,,,"Payments or transfers of value related to research are provided to a studys respective site and associated, per CMS requirements, with a Principal Investigator. The amount of this record may be associated with a payment or it may be associated with other transfers of value related to research, including, but not limited to, service costs, supplies, equipment and rentals, investigator meeting costs, and study drug."
9383,UNCHANGED,Covered Recipient Physician,,,,,143216.0,1164561767.0,MARIANNE,LYNN,BARAN,,23100 CHERRY HILL ST,SUITE 1,DEARBORN,MI,48124-1493,United States,,,Doctor of Dentistry,,,,,,Dental Providers|Dentist|General Practice,,,,,,MI,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Kerr Corporation,100000005552,Kerr Corporation,CA,United States,Yes,Covered,Device,RESTORATIVE DENTISTRY,HARMONIZE,,,,,,,,,,,,,,,,,,,,,,,,,,,200.0,07/30/2020,Cash or cash equivalent,,,,,,,No,No,HARMONIZE,No,750928457,2020,01/20/2023,,,
8841,UNCHANGED,Covered Recipient Teaching Hospital,,140010.0,9083.0,NORTHSHORE UNIVERSITY HEALTHSYSTEM,,,,,,,2650 Ridge Ave,,Evanston,IL,60201,United States,,,,,,,,,,,,,,,,,,,,Covered Recipient Teaching Hospital,294843.0,1508944018.0,EUGENE,F,YEN,,2650 RIDGE AVE,SUITE G221,EVANSTON,IL,60201-1718,United States,,,Medical Doctor,,,,,,Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology,,,,,,IL,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,AbbVie Inc.,100000000204,AbbVie Inc.,IL,United States,Yes,Covered,Biological,IMMUNOLOGY,SKYRIZI,0074-2042-02,,,,,,,,,,,,,,,,,,,,,,,,,,377.7,05/01/2020,Cash or cash equivalent,,,,,,,No,No,M16-000,No,721136459,2020,01/20/2023,NCT03105102,,
